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Abstract 
In different parts of the world, the use of medicinal plants has always been 
important in the therapeutic armory of mankind and remains an important source for 
the discovery of new bio-active compounds. Libya constitutes an apt example where 
medicinal plants are widely used. While some individual plant species such as 
Ginkgo biloba have been investigated in some detail, there is relatively little 
information available concerning the antioxidant potential and anticholinesterase 
activities of plant species in general and Libyan plants in particular. 
In this study twenty three Libyan medicinal plants were chosen for the study 
of antioxidant capacity and phenolic content. Aqueous plant extracts were screened 
for their antioxidant activity using the FRAP, TEAC and DPPH methods. These 
methods enable high-throughput screening of potential antioxidant capacity. Results 
show that of these twenty three plants, hot and cold extracts of Myrtus communis, 
Quercus robur and Syzygium aromaticum exhibited the strongest antioxidant activity 
in all tests and this is higher than that of the green tea control. It is suggested that the 
efficacy of these plants could be explained, at least in part, by their antioxidant 
activity. 
A selection of ten Libyan plants which have various ethnobotanical uses were 
evaluated for anticholinesterase activity. Most plants screened showed some 
inhibitory activity with either or both acetyl- and butyrylcholinesterase. 
Digestion is an initial step involving changes in pH and activity of proteolytic 
enzymes. Plant extracts were evaluated for possible changes in antioxidant properties 
and anticholinesterase activity using an artificial digestion technique. Most extracts 
showed an increase in antioxidant activity after the final pancreatin step although 
results varied with the antioxidant assay used. However, almost all anticholinesterase 
activity was lost at the HC1 stage of the in vitro digestion procedure. Testing in vitro 
bioavailability of plant extracts is a useful step in evaluating in vivo bioavailability. 
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Chapter 1 General Introduction 
1.1 . Definition of Free Radicals: 
Free radicals can be defined as any species capable of independent existence 
that contain one or more unpaired electrons (Halliwell et al., 1995, Halliwell and 
Gutteridge, 1999, Parsons, 2000, Halliwell, 2000). Oxygen free radicals or, more 
generally, reactive oxygen species (ROS), as well as reactive nitrogen species (RNS), 
are formed in all cells as unwanted by-products of metabolism and as such can be 
regarded as "toxic agents" with regard to their potential for initiating intracellular 
damage (Halliwell, 1995, Valko et al., 2007). They are characterized by the presence 
of unpaired electrons (conventionally denoted by a point suffix '). As a result of 
these unpaired electrons these species tend to attack stable molecules and take one of 
their electrons (to replace this missing electron), so that the previously stable 
molecule in turn becomes a free radical seeking to replace its missing electron and 
attack another molecule. This process is known as oxidation and the free radicals are 
responsible for the production of a chain of degradation. In biological systems free 
radicals are typically centred on oxygen, carbon or sulphur atoms. Most 
investigations have focused on oxygen centred radicals, with the hydroxyl (OH') and 
superoxide (02 ') radicals considered as the most physiologically powerful primary 
tissue damaging free radical species (Table 1.1). 
In addition, there are other important free radicals derived from these primary 
species including the peroxyl (R02') and alkoxyl (RO') species. The reactive oxygen 
species (ROS) include both radical and non radical substances. They include OH', 
O, RO2'and RO', and H202. Indeed, OH' and its subsequent radicals are the most 
1 
Table 1.1 Examples of free radicals (Halliwell and Gutteridge, 1999). 
Name Formula Comments 
Hydrogen atom H' The simplest free radical. 
Trichloromethyl CC13' A carbon- centred radical. These free 
radicals react rapidly with 02 to make 
peroxyl radicals. 
Superoxide 02 Oxygen- centred radicals. 
Hydroxyl OH' Highly reactive oxygen- centred 
radicals, attacks all biomoleclues. 
Thiyl/ perthiyl RS' /RSS' A group of radicals that have unpaired 
electrons residing on sulphur. 
Peroxyl, alkoxyl R02', RO' Oxygen-centred radicals formed 
during the breakdown of organic 
peroxides and reaction of carbon 
radicals with 02 (RO2* ). 
Oxides of nitrogen NO', N02' Nitric oxide is formed in vivo from the 
amino acid L-aginine; nitrogen 
dioxide is made when NO' reacts with 
02; both are found in polluted air and 
smoke from burning organic materials. 
Nitrogen-centred radicals- C6H5N=N' Formed during oxidation of 
phenylhydrazine by erythrocytes. 
2 
reactive free radical species in biological systems (Erel, 2004, Valko et al., 2007). On 
the other hand, 02 is less reactive than the OH' and its reactivity depends on pH 
(Morello et al., 2002, Valko et al., 2006). R02', RO' are good oxidizing agents as 
both can abstract hydrogen atoms from other molecules. Moreover, R02' can also 
react with each other to generate singlet oxygen. Although hydrogen peroxide (H202) 
is also capable of producing direct damage to the tissues, it is not classed as a free 
radical since it does not possess unpaired electrons. H202 is not very reactive but it is 
considered as a cytotoxic agent. It can inactivate enzymes with essential thiol (- SH) 
groups at the active site and it is capable of producing cell damage through reacting 
with metal ions to generate OH', which are more generally reactive (Parsons, 2000, 
Valko et al., 2006). 
3 
1.2 Source of free radicals: 
1.2.1 Cellular: 
ROS are produced in vivo mainly through the mitochondrial respiratory chain 
brought about by leakage of electrons from the electron carrier directly on to 02 
during the production of adenosine triphosphate (ATP) (Valko et al., 2004). About 1- 
3% of all electrons in the transport chain tend to generate 02 instead of contributing 
to the reduction of oxygen to water (Chance et al., 1979, Valko et al., 2007). In 
addition, they are also formed from the futile cycling of the various cytochrome 
P450s in the catalysis of microsomal oxygenation reactions (Basu et al., 1999). ROS 
are also formed by activation of leukocytes and during phagocytosis. Several 
enzymes such as xanthine oxidase have been identified that are capable of the 
production of 02 -Other 
ROS generating systems include auto-oxidation reactions; 
reduction of tissue 02 by metal redox systems such as Fe 2+ /Fe3+. The main source of 
OH', the most dangerous radical, comes from the interaction of hydrogen peroxide 
with transition ions such as Fe 2+ or Cue+. OH' are also formed when NO' and 02 
react to produce peroxynitrite (Mantle and Preedy, 1999). In general, generation of 
ROS seems to occur within all aerobic cells (Valko et al., 2006). 
2.2.1 Environmental: 
Reactive oxygen species can be produced by a set of exogenous processes. 
Environmental agents including non-genotoxic carcinogens can directly generate or 
indirectly induce reactive oxygen species in cells (Valko et al., 2006). Thus, people 
are exposed to free radicals from the external environment from smoking, chlorine in 
4 
drinking water, pollution in the atmosphere such as pesticides, food additives, drugs 
and antibiotics (Morello et al., 2002, Valko et al., 2007). Local environment and 
lifestyle play an important role in increasing free radical activity in the body. For 
example, smoking and poor diets result in increased free radical activity in the body 
(Scott, 1997, Abou-Seif, 1996). Moreover, it is well established that a number of 
gaseous products, found to varying degrees in industrial environments as pollutant 
gases, exert pro-oxidant effects in animal lungs (Scott, 1997, Valko et al., 2006). 
Epidemiological and experimental studies have indicated that cigarette smoking is 
considered as a major risk factor for numerous chronic diseases. Smoke contains a 
complex mixture of toxic agents including ROS and RNS, which mediate cell 
damage by stimulating lipid peroxidation and oxidation (Proteggente et al., 2006). In 
addition, cigarette smoke acts as an irritant and induces a localised inflammatory 
response resulting in generation of ROS by lung macrophages (Kalra et al., 1991, 
Scott, 1997). 
1.3 Mechanisms of ROS Toxicity: 
Free radicals have the potential to damage intracellular organelles and 
components such as nucleic acids, lipids and proteins on which normal cell function 
depends. Free radical oxidation damages the outer membrane of a cell and then 
continues into the cell where DNA is affected. Thus damage to the cell will be 
replicated each time during cell division (Valko et al., 2004, Halliwell and 
Gutteridge, 1999, Hillestrom et al., 2006). ROS are the mediators of inflammation 
and are involved in the pathogenesis of infectious disease, including septic shock, 
and immune diseases such as arthritis and inflammatory bowel disease (Parke et al., 
1991). Research in recent years has shown the importance of ROS in degenerative 
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processes related to aging (Ames et al., 1993) and diseases such as coronary heart 
disease, chronic renal failure, diabetes mellitus, immune dysfunction, atherosclerosis, 
cancer and neurodegenerative disorders such as Parkinson's and Alzheimer's 
diseases (Halliwell, 1994, Arts and Hollman, 2005, Ames, 1983, Arredondo et al., 
2004, Young and Woodside, 2001, Halliwell, 1996, Halliwell, 2002, Halliwell et al., 
1992, Chisolm and Steinberg, 2000, Morello et al., 2002, Basu et al., 1999, Wiseman 
and O'Reilly, 1997, Vanharanta et al., 2003). The molecular mechanisms of ROS 
toxicity and ROS- mediated disease include: 
i- Oxidation of vital thio compounds to disulphate. 
ii- Loss of tissue GSH (glutathione). 
iii- Impairment of energy generation (ATP, NADH, and NADPH). 
iv- Oxidation of cytoplasm. 
v- Inhibition of Ca 2+ transport and electrolyte homeostasis. 
vi- DNA cleavage 
vii- The initiation and promotion of mutations and carcinogenesis. 
1.4 Pathological Problems Associated with Free Radical Generation: 
Under normal physiological conditions there is a balance between both the 
activities and intracellular level of antioxidants. However, cellular injury resulting 
from the imbalance between the free radical generating and scavenging system 
"oxidative stress" has been implicated in the pathogenesis of a variety of disorders. 
These disorders include: 
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1.4.1 Cancer 
Oxidative damage to DNA, lipids and proteins in the human body is generally 
considered to be an important factor in carcinogenesis. Cancer initiation and 
promotion is associated with chromosomal defect and oncogene activation (Borek, 
2005, Adlercreutz, 1988, Valko et al., 2004). Exposure of organisms to ionizing 
radiation has long been known to help development of cancer later in life. Ionizing 
radiation is a complete carcinogen, being both an initiator and promoter (Kensler and 
Taffe, 1986, Ames et al., 1993). It is a reasonable possibility that some endogenous 
free radical reactions will result in tumour formation by serving as a continuous 
source of tumour initiators and promoters. A tumour may be defined as "an 
abnormal lump or mass of tissue, the growth of which exceeds and is uncoordinated 
with that of normal tissue, continuing after the stimuli that initiated it have ceased" 
(Halliwell and Gutteridge, 1999). The formation of tumour results from the 
breakdown of the normal intercellular collaboration. Some genetic damage by 
radiation occurs by direct absorption of energy by DNA, but some is mediated by 
ionization of water resulting in the formation of highly reactive OH', which in turn 
attacks DNA and generates mutations (Cerutti, 1994, Valko et al., 2006). Defects in 
DNA repair mechanisms also predispose to the development of cancer (Valko et al., 
2007). 
1.4.2 Diabetes mellitus 
Mellitus is a Latin word meaning "honey-sweet" and refers to the taste of 
diabetic urine. Diabetes mellitus is a chronic disease characterized by elevated blood 
glucose (hyperglycaemia) and urinary glucose excretion. It is caused by a fault in the 
insulin production or by a disorder in the response of tissue to it (insulin resistance). 
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Alloxan, a well known diabetogenic agent, appears to act by producing severe 
oxidative stress on the ß-cell, which is responsible for the production of insulin (Al- 
Azzawie and Alhamdani, 2006). It is still unclear whether oxidative stress 
contributes to the origin of diabetes in humans (Tang et al., 2006, Ananthan et al., 
2003). Recently, it has been proposed that some of the complications of diabetes, 
leading to mortality in diabetics, are associated with the increased activity of ROS 
and oxidative cellular damage (Pratico, 2005, McCune and Johns, 2002, Astaneie et 
al., 2005, Liu, 2002). 
1.4.3 Cardiovascular Diseases (CVD) 
The ROS- induced oxidative stress in cardiac and vascular myocytes has been 
linked with cardiovascular tissue injury. Regardless of the direct evidence for a link 
between oxidative stress and cardiovascular diseases, ROS- induced oxidative stress 
plays a major role in various cardiovascular diseases such as atherosclerosis, 
ischemic heart disease, hypertension, coronary heart disease and congestive heart 
failure (Adorn et all., 2003, Arts and Hollman, 2005, Manach et al., 2005). 
1.4.3.1 Atherosclerosis 
Atherosclerosis is an arterial disease that is characterized by a local thickening 
of the vessel wall that develops in the inner coat. Epidemiological evidence suggests 
that the high concentration of cholesterol in plasma, especially in the form of low- 
density lipoprotein (LDL), is a high predictor of atherosclerotic risk. LDL is 
susceptible to modification particularly by oxidation. Besides high levels of 
cholesterol, uptake of oxidised low density cholesterol (LDLox) seems be a key step 
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in the development of atherosclerosis. The likely candidate responsible for the 
oxidative modification of LDL in arterial cells is the oxygen- derived free radical. 
Oxidised lipoprotein and LDLox have been reported to mediate enhanced superoxide 
formation, which in turn leads to apoptosis of cells in the umbilical vascular wall. 
LDLox- mediated formation of ROS also cause plaque formation. In addition to the 
direct effect of 02 Th, oxidation of NO by 02 results in the formation of 
peroxynitrite which is known to initiate lipid peroxidation or lipoprotein oxidation, 
both important events in the incidence of atherosclerosis (Valko et al., 2007). 
Furthermore, several reports have discussed the involvement of the free radicals in 
the development and initiation of atherosclerosis (Darley-Usmar and Halliwell, 1996, 
Parthasarathy, 1992, Kumpulainen and Salonen, 1996, Pratico, 2005). 
1.4.3.2 Coronary heart disease 
Coronary heart disease (CHD) is a condition in which the heart muscle receives 
an inadequate amount of blood because of an interruption of its blood supply. There 
is increasing evidence to support the hypothesis that free radical-mediated oxidative 
processes contribute to coronary heart disease (Adlercreutz et al., 2004, Anderson, 
2004, Maxwell and Lip, 1997). The development of atherosclerotic lesions in the 
coronary arteries of heart, if not treated, may lead to CHD, the leading cause of death 
in affluent communities (Basu et al., 1999). 
1.4.4 Inflammatory disease 
When cells are damaged by microbes, physical agents, or chemical agents, the 
injury sets off inflammation (inflammatory response). It is becoming increasingly 
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apparent that certain types of inflammatory tissue injury are mediated by reactive 
oxygen metabolites (Aruoma, 2003). The most likely sources of these oxidizing 
agents are the phagocytic leukocytes (e. g., neutrophils, monocytes, macrophages, and 
eosinophils) that damage the tissue (Russo et al., 2005, Conner and Grisham, 1996). 
These reactive radicals and oxidants may injure cells and tissue directly via oxidative 
degradation of essential cellular components as well as injure cells indirectly by 
altering the balance that normally exists within the tissue interstitium. It has been 
demonstrated that nitric oxide (NO*) is involved in the pathogenesis of acute and 
chronic inflammation. During inflammation, nitric oxide is synthesized in 
significantly large quantities and may be become cytotoxic. The free radical nature of 
NO and its high reactivity with 02 to produce peroxynitrite (ONOO-), which can 
cause DNA fragmentation, makes NO* a potent pro-oxidant molecule able to induce 
oxidative injury and to be potentially harmful toward cellular targets (Vouldoukis et 
al., 2004, Manach et al., 2005, Tiwari and Tripathi, 2007, Padwad et al., 2006). 
1.4.5 Neurodegenerative disorders 
The brain is particularly highly susceptible to oxidative damage because of its 
high oxygen utilisation (Ono et al., 2006, Shen, 2004). It has a high content of 
oxidizable polyunsaturated fatty acids and possesses redox- active metals such as Fe 
and Cu. Oxidative stress increases with age and consequently it can be considered as 
a very important causative factor in several neurodegenerative diseases, typically for 
older individuals (Auddy et al., 2003, Landsberg, 2005). 
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1.4.5.1 Alzheimer's disease 
Alzheimer's disease (AD) is a progressive neurodegenerative disorder 
characterized by impairment of memory and cognition, and behavioural problems. It 
is the most common dementia in Western societies and accounts for two-thirds of all 
dementia cases (Choudhary et al., 2005b, Inestrosa et al., 2005, Obermayr et al., 
2005). Pathologically, AD is characterized by loss of cholinergic neurons from 
selective brain regions. The first evidence in support of the implication of oxidative 
stress in pathogenesis of AD was reported by Martins et al. (1986). Cells in the 
brains of AD patients exhibit an abnormally significant extent of oxidative damage 
associated with a marked accumulation of amyloid-ß peptide (Aß), the main 
constituent of senile plaques in the brain, as well as deposition of neurofibrillary 
tangles and neurophil threads. AD is multifactorial with both genetic and 
environmental factors implicated in its pathogenesis (Kasa et al., 2000, Gil-Bea et al., 
2005). For a number of years, two major hypotheses on the cause of AD have been 
proposed: the "amyloid cascade hypothesis", which states that the neurodegenerative 
process is a series of events triggered by abnormal processing of the amyloid 
precursor protein; and the "neuronal cytoskeletal degeneration hypothesis", which 
proposes that cytoskeletal changes are the trigger of events. Recently, a new 
hypothesis seeking to incorporate the multifaceted nature of both the triggering 
mechanisms and progression of AD has proposed that AD results from a disorder of 
the mechanisms underlying structural brain self-organization/plasticity (Shen, 2004). 
Acetylcholinesterase (AChE) is a key component of cholinergic brain synapses and 
neuromuscular junctions. The major biological role of the enzyme is the termination 
of impulse transmission by rapid hydrolysis of the cationic neurotransmitter 
acetylcholine (ACh). According to the cholinergic hypothesis, memory impairments 
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in patients with senile dementia are due to a selective and irreversible deficiency in 
the cholinergic functions in the brain (Shen, 2004, Choudhary et al., 2005c, Garcia- 
Alloza et al., 2005). 
1.4.5.2 Parkinson's disease 
Parkinson's disease (PD) is the second most common degenerative disorder, 
affecting approximately 10% of the population over 65. It was first described by the 
English physician James Parkinson as the `shaking palsy' in 1817. PD is 
characterised by a rhythmic tremor in foot or hand, especially when the limbs are at 
rest. As the disease develops, patients begin to have increasing problems in 
controlling movement including slowing and initiation of movement and rigidity of 
muscles (Halliwell and Gutteridge, 1999). Pathologically, PD involves a selective 
loss of dopaminergic neurons in an area of the midbrain called the substantia nigra. 
These cells use dopamine, a neurotransmitter between brain and nerve cells, to 
communicate with the cells in another region of the brain called the striatia (Ruberg 
et al., 1986, Thibaut et al., 1995). The clinical syndrome appears when 
approximately 80% of striatal dopamine has been lost. Although PD is a 
multifactorial disorder, cumulative evidence supports an "oxidative stress 
hypothesis" for initiation of nigral dopamine neuron loss. The foundation for this 
hypothesis is the pro-oxidative state of the substantia nigra. Essentially, the 
substantia nigra has a high metabolic rate combined with both a high content of 
oxidizable species, including dopamine, neuromelanin, poly-unsaturated fatty acids 
and iron, and a low content of antioxidants (especially glutathione) (Halliwell and 
Gutteridge, 1999). Thus, oxidative stress can easily overwhelm the natural defences, 
resulting in production of ROS which serve both to maintain the oxidative stress 
level and initiate/propagate apoptosis of the dopaminergic neurons. One important 
feature of this hypothesis is that it allows a transient initiation factor to trigger an 
active, self-petuating cycle of inflammation and neurodegeneration that ultimately 
destroys enough of the dopaminergic neurons in the substantia nigra to produce the 
clinical syndrome of PD (Valko et al., -1007). 
Occurrence of oxidative stress in PD is 
supported by both post-mortem studies and by studies demonstrating the capacity of 
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oxidative stress to induce nigral cell degeneration (Piggott et al., 2003, Valko et al., 
2007). 
1.4.6 Aging 
The process of aging may be defined as a progressive decline in physiological 
functions of organisms after the reproductive phase of life (Araujo et al., 2005, Ames 
et al., 1993). Most old animals and humans have obvious or sub clinical diseases 
such as atherosclerosis and amyloid-ß plaques that can influence parameters of 
oxidative damage. The first direct experimental support of the implication of free 
radicals in the aging process was in 1957 by Harman (Harman, 1957), who proposed 
that normal aging results from random deleterious damage to tissue by free radicals 
(Harman, 1993). Indeed, this report has gradually triggered intense research into the 
field of the role of free radicals in biological systems (Araujo et al., 2005). Among 
the many theories describing the process of aging that have been proposed, it is now 
believed that free radical damage theory seems to be the most considered approach to 
explain the process of aging (Halliwell and Gutteridge, 1999). It is based on the fact 
that free radical damage to mitochondria results in mitochondrial DNA mutations, 
leading to a progressive reduction in cellular energy supply, and consequential 
physiological decline characterized by the inactivation of key enzymes and 
accumulation of oxidized proteins (Araujo et al., 2005). 
1.5 Biological Defence Systems: 
Exposure to free radicals from internal and external sources has led organisms 
to develop a series of biological defence mechanisms against oxidative damage 
induced by reactive oxygen species. The biological defence systems involve 
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preventative mechanisms, repair mechanisms and physical defences. These are 
dependent upon antioxidants. 
1.5.1 Definition of Antioxidants: 
Antioxidants can be defined as "any substance that when present at low 
concentrations compared to those of an oxidizable substance significantly delay or 
prevent a pro-oxidant initiated oxidation of that substrate" (Halliwell, 1995). 
Antioxidant compounds must be present in biological systems in sufficient 
concentrations to prevent an accumulation of pro-oxidant molecules, a state known 
as oxidative stress (Buettner and Schafer, 2000, Wiseman and O'Reilly, 1997). Cells 
are protected from free radical induced-damage by a complex array of endogenous 
radical scavenging proteins, enzymes, numerous endogenous antioxidant factors, that 
include coenzyme Q, glutathione GSH and other tissue thiols, metal ion sequestering 
proteins such as oxidizing (Fe2+) to (Fe3+), ROS metabolising enzymes such 
superoxide dismutase, and catalase. In addition, there are other important antioxidant 
compounds including a-tocopherol (vitamin E), ascorbic acid (vitamin C), uric acid, 
and the histidine containing dipeptides carnosine and anserine (Hussin et al., 2007). 
Besides these compounds, there are a variety of plant derived dietary compounds 
which act as antioxidants such as carotenoids and flavonoids (Prenesti et al., 2007, 
Montoro et al., 2005, Yu et al., 2005) (Table 1.2 ). 
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Table 1.2 Antioxidant defence (adapted from Basu et al, 1999). 
Endogenous factors Endogenous enzymes Nutritional factors 
Glutathione and other thiols GSH reductase 
Haem proteins GSH transferase 
Vitamin C 
Vitamin E 
Coenenzyme Q GSH peroxidase ß- Carotene and retinoids 
Bilirubin Superoxide dismutase Selenium-essential dietary 
component of glutathione 
peroxidases 
Uric acid Catalase Methionine or lipotropes 
1.5.2 Antioxidant defence mechanisms: 
Antioxidants play the housekeeper's role, "mopping up" free radicals before 
they get a chance to cause injury. Generally, as shown in Figure 1.1, defence systems 
against oxidative damage are composed of various antioxidants with different 
functions including: (a) preventive antioxidants, which suppress the formation of free 
radicals, (b) radical-scavenging antioxidants, which scavenge radicals to inhibit 
chain initiation and break chain propagation, (c) repair and de novo enzymes, that 
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Figure 1.1 Defence system in vivo against oxidative damage (Niki, 1996). 
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repair the damage and reconstitute membranes and (d) adaptation, by generation of 
appropriate antioxidant enzymes and transfer of them to the right site at the right 
time and in the right concentration. Antioxidants can either act by interfering with 
the propagation stage of free radical generation itself or act directly as free radical 
scavengers (Pool-Zobel et al., 2000). There are many enzymatic and non enzymatic 
antioxidant defence systems in the body that remove toxic species by means of the 
following mechanisms: 
1. Enzymatic defence mechanism which is achieved by the endogenous 
enzymes as mentioned in Table 1.2. These enzymes act against the free 
radical action, either by enzymatic hydrolysis of ester bonds to remove 
peroxidized fatty acids or by sequestration of transition metal ions or 
by enzyme catalysed reduction of peroxides. 
2. Non enzymatic defence mechanism, which is also called sacrificial 
mechanism as the antioxidant compound sacrifices one of its electrons 
and changes to a relatively unreactive radical. This mechanism can be 
performed by low molecular weight antioxidants such vitamins C and 
E, uric acid, glutathione, carotenoids and flavonoids which act as 
scavengers and prevent free radical propagation. 
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1.5.3 Analytical methods for measuring antioxidant activity: 
Antioxidant activity cannot be measured directly but rather by the effects of 
antioxidant in controlling the extent of oxidation. A wide range of methods are 
currently used to assess antioxidant capacity in food, botanicals, nutraceuticals and 
other dietary supplements. Both in vivo and in vitro assays are used and all methods 
have their own advantages and limitations. In the literature, numerous reports have 
reviewed the advantages and disadvantages of various methods that have been used 
for the measurement of antioxidants (Frankel and Meyer, 2000, Antolovich et al., 
2002, Halliwell and Gutteridge, 1995, Prior and Cao, 1999, Prior et al., 2005, 
Schlesier et al., 2002). Although there is a great multiplicity of methods used for 
antioxidant testing, none of these methods provide an ideal individual, approved, 
standardised method, as within biological systems, there are several sources of 
antioxidant including enzymes (such as superoxide dimutase, glutathione peroxidise 
and catalase), large molecules (like albumin and ferritin), small molecules (uric acid 
and polyphenols), some hormones (melatonin and estrogen) and molecules of dietary 
origin molecules such as vitamin C, carotenoids, flavonoids, etc. On the other hand, 
both oxidants and antioxidants may have different chemical and physical features. 
Furthermore, antioxidants may respond in different manners to different radical or 
oxidant sources (Prior et al., 2005). Therefore, to assess and describe the total 
antioxidant activity of any sample, more than one analytical assay must be applied 
(Frankel and Meyer, 2000). In general, all methods that have been used are based on 
two major mechanisms by which the antioxidant capability to deactivate the radicals 
is associated (Prior et al., 2005): 
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1- Hydrogen Atom Transfer (HAT) based method: 
It measures the ability of antioxidant to quench free radicals by hydrogen 
donation (AH= any H donor). 
X +AH -*XH+A* 
2- Single Electron Transfer (SET) based method: 
It detects the ability of a potential antioxidant to transfer one electron to 
reduce any compound, including metal, carbonyl and radicals 
X'+AH -X"+AH'+ (1) 
AH*+ + H20+-> A'+ H3O + (2) 
X"+H3O+-*XH+H20 (3) 
M (III) + AH -* AH+ +M (II) (4) 
The most widely and frequently used analytical methods are ferric reducing 
antioxidant power (FRAP) (Benzie and Strain, 1996, Benzie and Strain, 1999) (µmol 
ferrous ion equivalents); Trolox equivalent antioxidant capacity (TEAL) (Re et al., 
1999) (mmol Trolox equivalents) and scavenging activity of 1,1' -diphenyl-2-picryl- 
hydrazyl (DPPH) radicals (Brand-Williams et al., 1995, Blois, 1958, Koleva et al., 
2002) (mmol Trolox equivalents). These methods have gained popularity because 
they enable high-throughput screening of potential antioxidant capacity. ' 
1.5.3.1 Ferric reducing antioxidant power (FRAP) assay: 
The FRAP assay was first introduced by Benzie and Strain (1996; 1999) for 
measuring the total antioxidant activity. The assay is based on the reducing power of 
a compound (antioxidant). A potent antioxidant will reduce the ferric ion (Fe3+) to 
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the ferrous ion (Fe2+). The ferrous ion forms a blue complex (Fe 2+/2,4,6-tripyridyl- 
s-triazine (TPTZ). The resulting blue colour can be measured spectrophotomertically 
and is linearly related to the total reducing capacity of electron-donating 
antioxidants. The higher the absorbance the higher the reducing power of the 
phytochemical, thus higher antioxidant activity (See Methods 2.2.3.1). 
1.5.3.2 Trolox equivalent antioxidant capacity (TEAL) assay: 
The TEAC assay was originally described by Miller et al. (1993). It has since 
been improved by modifications regarding free radical generation (Van den Berg et 
al., 1999, Re et al., 1999) and is based on the relative ability of antioxidants to 
scavenge the radical cation 2,2'-azinobis-3-ethylbenzothiazoline-6-sulphonate 
(ABTS+). The extent of quenching of the ABTS+ radical by the test medium is 
measured spectrophotometri cally and compared with that of Trolox, a water-soluble 
vitamin E analogue (See Methods 2.2.3.2) with proven antioxidant properties. 
1.5.3.3 Diphenyl-2-picryl-hydrazyl (DPPH) radical assay: 
Radical scavenging activity using the DPPH method was described by Blois 
(1958). The essence of the DPPH method is that the antioxidant reacts with stable 
free radicals either by transferring electrons or hydrogen atoms to DPPH, thus 
neutralising free radical character (Naik et al., 2003). i. e., 1,1'-diphenyl-2-picryl- 
hydrazyl (deep violet colour) is converted to 1,1'-diphenyl-2-picryl-hydrazine 
(yellow). Therefore, the colour of the reaction mixture changes from deep violet to 
yellow and its absorbance decreases. The degree of discolouration indicates the 
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scavenging potential of the sample antioxidant (Abdille et al., 2005, Tepe et al., 
2005a, Tsao and Deng, 2004) (See Methods 2.2.3.3). 
1.6 Therapeutic intervention: 
Oxidative stress has been confirmed to be involved in all previously mentioned 
diseases. In some it makes a significant contribution to tissue damage. Such diseases 
should be amenable to therapeutic intervention with antioxidants. For instance, 
Tamoxifen is widely used in the treatment of breast cancer and has also reported to 
have beneficial effects against cardiovascular system (CVS) and particularly CHD by 
retarding the peroxidation of human LDL (Bingham et al., 1998). In addition, in 
some acute diseases involving peroxidation, antioxidant therapy is already becoming 
well established (Scott, 1997, Salonen et al., 2000, Valko et al., 2006, McCune and 
Johns, 2002). Furthermore, inhibition of NO production in response to inflammatory 
stimuli is considered as a useful therapeutic strategy in inflammatory disease 
(Padwad et al., 2006). Although multiple types of intervention by a variety of 
antioxidants have been shown to have beneficial effects in animals, very few have 
been developed as therapeutic agents in man (Dunnett and Svendsen, 1993, 
Obermayr et al., 2005). The reason for this is almost certainly associated with reports 
regarding their carcinogenic properties (Halliwell and Gutteridge, 1999, Padwad et 
al., 2006). 
1.7 Synthetic antioxidants 
Synthetic antioxidants which contain phenolic groups such as gallic acid 
esters, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), and 
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tertiary butylhydroxyquinone (BHQ), are the most widely used food synthetic 
antioxidants. In spite of the widespread use of these artificial antioxidants, there is 
increasing concern over their safety. Currently used synthetic antioxidants have been 
suspected to cause or promote negative health effects (Amarowicz et al., 2004); thus 
the replacement of synthetic antioxidants by safe natural antioxidants such as vitamin 
E and C, flavonoids and other plant phenolics has been increasingly supported (Duan 
et al., 2006). 
On the other hand, there is evidence that some drugs that are already used 
clinically may exert some part or all of their effects by antioxidant mechanisms. 
However, these drugs were not designed as antioxidants. Recently, several studies 
showed that many drugs approved for therapeutic use such as those used in the 
treatment of diabetes, may have a number of serious adverse effects including 
hepatotoxicity (Tang et al., 2006, May et al., 2003, Kim and Kim, 2006). However, 
restrictions have been placed on their application. In general, only a few drugs would 
appear capable of acting directly as antioxidant in vivo. In fact, several drugs that are 
used in the treatment of various disorders, such as anti-flammatory drugs, might 
themselves be converted into free radicals in vivo and aggravate oxidative damage 
(Halliwell and Gutteridge, 1999). Therefore, there is a trend to substitute synthetic 
antioxidant drugs with naturally occurring antioxidants. 
1.8 Correlation between antioxidant and neuroprotective effects: 
Oxidative stress is involved in acute and chronic neurodegenerative 
conditions, such as ischaemia-reperfusion injuries, infectious processes (e. g., AIDS) 
and Alzheimer's and Parkinson's diseases (Sun et al., 2002, Aruoma et al., 2003). A 
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common feature of these pathological conditions is generation of mitochondri ally- 
derived reactive oxygen species (ROS). In nerve cells, the sources of ROS and NOS 
are numerous; therefore, cells have to maintain an effective antioxidant system in 
order to protect themselves against free radical overload and subsequent damage. 
Antioxidants can scavenge ROS and also can alter inflammation pathways. As a 
consequence, the use of antioxidants may be useful in the treatment of AD. More 
recent evidence in the form of antioxidant protection against development of AD 
lesion suggests vitamins E and C should be taken together to be more beneficial, as 
vitamin C recycles vitamin E to its active form (El-Demerdash et al., 2005). 
Epidemiological studies indicate that dietary antioxidants can influence the incidence 
of neurodegenerative diseases (Arredondo et al., 2004, Cal et al., 2004). Among 
those, flavonoids have been proposed to be effective cytoprotectors. Flavonoids are 
polyphenolic compounds and structurally have variations in the carbon ring that 
characterize the different types. Flavonoids are also considered to be the active 
ingredients in some medicinal plants. They are increasingly appreciated as 
chemopreventive agents against pathophysiological conditions, such as cancer, 
cardiovascular disease and neurodegenerative diseases in which free radicals have 
been implicated (Aruoma et al., 2003, Eccleston et al., 2002, Wiseman, 1996). The 
biological functions of these molecules such as anti-mutagenic, anti-carcinogenic and 
anti-ageing and others could be at least partially due to their antioxidant and free 
radical-scavenging activity. The primary activity of plant flavonoids is believed to 
reside in their free radical-scavenging capacity (Sala et al., 2003, Rice-Evans et al., 
1996, Ishige et al., 2001). They appear to minimize the number of oxidative DNA 
mutations and protein modifications by scavenging harmful reactive oxygen species 
(Djeridane et al., 2006, Sutherland et al., 2006). Moreover, some flavonoids show 
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other activities such as antiproliferative and pro-apoptotic effects, probably through 
interactions with key enzymes regulating cell cycle and apoptosis pathways (Torres 
et al., 2005). The nueroprotective properties of flavonoids, as effective for improving 
learning and memory, are rapidly becoming established (Sutherland et al., 2006). 
Consequently, herbs with a high concentration of these compounds such as 
Achyrocline satureioides, Ginkgo biloba and Epilobium parviflorum are of special 
interest (Arredondo et al., 2004, Howes and Houghton, 2003). 
1.9 Neuroprotective effects of anticholinesterase 
Esterases that catalyze the hydrolysis of choline esters at a higher rate than 
other esterases have been classified as cholinesterases (ChEs). Cholinesterase 
inhibitors have been used in the treatment of human diseases, the control of insect 
pests, and more notoriously as chemical warfare agents. Most uses of cholinesterase 
inhibitors are based on a common mechanism of action initiated by inhibition of 
acetylcholinesterase (AChE) (Pope et al., 2005). According to substrate specificities 
and susceptibility to inhibitors, this group of enzymes was divided into two major 
categories. The first category is plasma butyrylcholinesterase (BuChE) (EC 3.1.1.8), 
also known as acylcholine acetyl hydrolase, non-specific, pseudo, or type II 
cholinesterase (Quinn, 1987, Godkar et al., 2006). This enzyme is found principally 
in plasma and it acts on a variety of choline phenyl, nitro phenyl and other types of 
esters. The second category is acetylcholinesterase (AChE) (EC 3.1.1.7), which is 
also called "red cell", true, specific or type I cholinesterase. AchE exists primarily in 
nerve cells and muscular junctions, but it is also found in other neural and non neural 
cells. AChE plays an important role in terminating the nerve impulse in the 
cholinergic synapses by hydrolysis or breakdown of acetylcholine (ACh), the 
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excitatory neurotransmitter, into acetic acid and choline as shown in the equation 
below: 
AChE 
(CH3)3N+CH2O00CH3 H 
H2O 
Acetylcholine 
(CH3)3N+CH2OH + CH3CO2H 
choline acetic acid 
Cholinesterase inhibitors thus share a common mechanism of pharmacological 
or toxicological action, ultimately modifying cholinergic signalling through 
disruption of acetylcholine degradation. While the use of cholinesterase inhibitors 
relies on their interaction with AChE, a variety of reports indicate that a number of 
cholinesterase inhibitors have additional sites of action that may have 
pharmacological or toxicological relevance (Pope et al., 2005). Several studies 
suggested that the AChE enzyme has a greater specify for hydrolysing ACh. 
However, in the absence of the effective AChE enzyme, the reaction which is shown 
above is inhibited and the liberated ACh accumulates, preventing the smooth 
transmission of nerve impulses across the synaptic gap at nerve junctions (Quinn, 
1987, Pope et al., 2005). This causes loss of coordination, convulsion and ultimately 
death. AChE is therefore a key component of cholinergic brain synapses and 
neuromuscular junctions (Pope et al., 2005). The major biological role of the enzyme 
is the termination of impulse transmission by rapid hydrolysis of the cationic 
neurotransmitter acetylcholine. According to the cholinergic hypothesis, memory 
impairments in patients with senile dementia diseases are due to a selective and 
irreversible deficiency in the cholinergic functions in the brain. The role of BuChE in 
normal aging and brain diseases is still indefinable. It has been found that BuChE is 
present in significantly higher quantities in Alzheimer's plaques than in plaques of 
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normal age-related non-demented brains (Choudhary et al., 2005b, Orhan et al., 
2004). Alzheimer's disease (AD) is neuropathologically associated with a cholinergic 
deficiency. Therefore, ACh replacement therapy has been used as a potential strategy 
to improve AD pathology, mainly by inhibiting AChE (Ezoulin et al., 2005, Ferreira 
et al., 2006, Howes and Houghton, 2003). Encouraging results have been obtained 
with tacrine, galanthamine, rivastigmine and donepezil, but not without important 
side effects such as nausea and liver damage (Hu et al., 2005, Orhan et al., 2004). A 
number of novel natural inhibitors of cholinesterases (AChE and BuChE), isolated 
from different medicinally important plants, has been reported. (Choudhary et al., 
2005c, Godkar et al., 2006, Orhan et al., 2004, Howes and Houghton, 2003). These 
reports have identified natural compounds that have appreciable inhibitory potential 
against cholinesterase enzymes. 
1.10 Future Therapy 
In general, the human body is much better suited to be treated with herbal 
remedies than synthesized chemical medicines Plants play a major role in the 
introduction of new therapeutic agents and have received much attention as a source 
of biologically active substances including antioxidants and anticholinesterase. 
According to recent epidemiological reports carotenoids and polyphenolic 
compounds (flavonoids in particular) may exert beneficial effects by reducing cancer 
risk (Arts and Hollman, 2005, Bravo, 1998, Lopez et al., 2003). Essential nutrients 
such as vitamins C and E may protect against oxidant-mediated inflammation and 
tissue damage by virtue of their ability to scavenge free radicals. Thus, maintaining 
adequate antioxidant status may provide a useful approach in attenuating the cellular 
injury and dysfunction observed in some inflammatory disorders. The production of 
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free radicals may stimulate the processes of atherosclerosis, and antioxidant vitamins 
(including ß-carotene), which partly prevent such processes, might favorably 
influence cardiovascular disease (CVD). Thus, their supplementation might be a 
useful tool in the prevention of coronary heart disease (CHD). The evidence from 
case-control studies supports a role of ß-carotene in the prevention of CHD (Tavani 
and La Vecchia, 1999, Visioli et al., 2000, Vanharanta et al., 2003). Recently an 
intensive search for novel types of antioxidants has been carried out from numerous 
plant materials. 
The synthetic cholinesterase inhibitor tetrahydroaminoacri dine (THA) has been 
approved for patient treatment in several countries, and is effective in reducing 
cognitive impairment in approximately 30% of AD. However, side effects such as 
liver damage are recognized as serious problems in the use of such drugs (Mantle et 
al., 2000a, Orhan et al., 2004, Howes and Houghton, 2003). Therefore, the discovery 
of new cholinesterase inhibitors has been a challenging area of drug development 
due to the involvement of cholinesterases in Alzheimer's disease and other related 
dementias. 
1.11 Traditional medicinal plants 
In different parts of the world, the uses of medicinal plants have always had 
an important place in the therapeutic armoury of mankind. Herbal medicine still 
represents a very important phenomenon in traditional cultures. However, the use of 
pharmaceutical products of plant origin is a growing area in the treatment of several 
illnesses and competes with popular medicine. Nevertheless, in some countryside 
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areas, traditional remedies are still widely used and go side by side with the use of 
modern pharmaceuticals and often, especially in cases of minor illness, they totally 
substitute them. Up to 80% of populations in developing counties rely on herbal 
plants for their primary health care (Ferreira et al., 2006). As a consequence of 
expensive costs of prescription medicine, the development and reliance on traditional 
treatment has been encouraged. 
The preservative effect of many plant spices and herbs suggests the presence 
of antioxidative and antimicrobial constituents in their tissues (Mansouri et al., 2001, 
Romani et al., 2004). Polyphenols are a large family of natural compounds widely 
distributed in plant foods. They can be classified into two categories, phenolic acids, 
which account for about one third of the total intake of polyphenols, and flavonoids 
accounting for the remaining two thirds (Table 1.3). Flavonoids and phenolic acids 
can act as antioxidants by a number of potential pathways. These phytochemicals 
that possess significant antioxidant capacities are associated with lower occurrence 
and lower mortality rates of several human diseases. Many medicinal plants contain 
large amounts of antioxidants such as polyphenols, which can play an important role 
in adsorbing and neutralizing free radicals, quenching singlet and triplet oxygen, or 
decomposing peroxides (Boskou et al., 2006). Therefore, research to identify 
antioxidative compounds is an important issue. Although it remains unclear which of 
the compounds of medical plants are the active ones, polyphenols recently have 
received increasing attention because of some interesting new findings regarding 
their biological activities. From pharmacological and therapeutic points of view, the 
antioxidant properties of polyphenols, such as free radical scavenging and inhibition 
of lipid peroxidation, are the most crucial. Even though a variety of herbs are known 
to be sources of phenolic compounds, studies isolating polyphenols and evaluating 
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their antioxidative effects have rarely been carried out. Recently, there has been an 
upsurge of interest in the therapeutic potential of traditional medicinal plants as 
antioxidants in reducing such free radicals induced by tissue injury. 
Table 1.3 Some dietary sources of polyphenols (adapted from Halliwell and 
Gutteridge, 1999). 
Polyphenols Source 
Phenolic acids 
Caffeic acid Coffee, grape, olive, plums, cherries 
Gallic acid blueberries 
Flavonoids 
Anthocyanins Bilberry, strawberries, berries 
Catechins or Flavanol Grape seed, tea, apples 
flavanones Citrus fruits 
Tannins Tea, nuts 
Procyanidins Apples, grapes, cocoa 
Proanthocyanidins Grapes 
Isoflavones Soy 
Flavonol Onion, tea, olive, apples 
Traditional or folk medicines have been widely employed for centuries, and 
they remain an important source for the discovery of new bio-active compounds. The 
scientific evidence that plant-based diets, in particular those rich in vegetable and 
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fruits, protect against cancer has been found to be strong and consistent by an expert 
panel (Basu et al., 1999). Recently, several medicinal plants from different countries 
have been screened for their antioxidant capacity (Table 1.4). 
Table 1.4 Summaries of the countries from which native medicinal plants have been 
screened for antioxidant capacity and their references. 
Original country of medicinal plants 
Brazilian medicinal plants 
Indian medicinal plants 
British medicinal plants 
Portuguese medicinal plants 
Canadian medicinal plants 
Bulgarian medicinal plants 
Lithuanian medicinal plants 
Spain medicinal plants 
Thailand medicinal plants 
Chinese medicinal plants 
Croatian medicinal plants 
Turkish medicinal plants 
Algerian medicinal plants 
Iranian medicinal plants 
References 
(Mensor et al., 2001, Silva et al., 2005) 
(Jadhav and Bhutani, 2002) 
(Mantle et al., 1998, Mantle et al., 2000b, 
Mantle et al., 2000a) 
(Ferreira et al., 2006) 
(McCune and Johns, 2002, Owen and 
Johns, 2002) 
(Ivanova et al., 2005) 
(Miliauskas et al., 2004b, Dapkevicius et 
al., 1998) 
(Navarro et al., 2003) 
(Chanwitheesuk et al., 2005) 
(Yingming et al., 2004, Cai et al., 2004) 
(Katalinic et al., 2006) 
(Tepe et al., 2006, Tepe et al., 2005a) 
(Djeridane et al., 2006) 
(Souri et al., 2004) 
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Medicinal plant extracts could be therapeutically useful for several apparently 
unrelated syndromes by virtue of synergistic effects of two or more components that 
complement each other in vivo through restorative / activation functions. Several 
studies have reported that many medicinal plants, such as Bauhinia monandra, Olea 
europaea, Gymnema montanum, Rhizoma coptidis and Eugenia jambolana which 
have proven successful in treating diabetes, also possess high antioxidant capacity. 
Therefore, this activity might be correlated with the presence of antioxidant 
components (Argolo et al., 2004, Al-Azzawie and Alhamdani, 2006, Ananthan et al., 
2003). Over the last thirty years, there have been numerous broad-base screening 
programmes in which large numbers of plant species world wide have been 
evaluated for their therapeutic activities such as antioxidant and anticholinesterase 
activities. The screening results showed that some plants have a variety of chemical 
constituents such as flavonoids, tannins, alkaloids and monoterpenes, which have the 
ability to inhibit AChE and act as free radical scavengers (Perry et al., 2003, Howes 
and Houghton, 2003, Vasudevan and Parle, 2006, Ferreira et al., 2006, Ravi et al., 
2004, Tang et al., 2006). 
In recent times, the focus on plant research has increased globally and the 
large body of evidence collected shows the immense potential of medicinal plants. 
Numerous herbal extracts, containing several active constituents and often more than 
one plant species, have been used to treat CNS-related disorders. Several studies 
have now been undertaken to scientifically investigate the traditional (CNS-related) 
use of Salvia lavandulaefolia (a sage species that contains only trace amounts of the 
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convulsant thujone) relevant to the treatment of Alzheimer's disease. These have 
centred on the activity of the essential (volatile) oil (Perry et al., 2003). In a study of 
the traditional Chinese herbs, Hu et al. (2005) found that aqueous extracts of the 
traditional Chinese herb Rhizoma anemarrhenae improved memory and raised the 
brain Muscarinic receptor density in aged animals by inhibition of 
acetylcholinesterase. Recently, extracts of Thespesia populnea, a large tree found in 
the tropical regions and coastal forests of India, have been shown to elevate 
acetylcholine levels in the brain and ultimately improve memory of both young and 
aged mice. In the light of the above, it may be worthwhile to explore the potential of 
this plant in the management of Alzheimer patients (Vasudevan and Parle, 2006). In 
addition, Celastrus paniculatus (CP), a medicinal plant from India, reputed to be 
useful as a pharmaceutical aid for learning and memory, has been investigated (Gattu 
et al., 1997). The inhibitory activities of selected Turkish medicinal plants, with 
various ethnobotanical uses, have been screened with the aim of discovering new 
candidates for anticholinesterase compounds (Orhan et al., 2004). Other studies have 
reviewed the pharmacological basis of some plants and their active constituents that 
have been used in traditional Ayurvedic medicine and Traditional Chinese medicine 
(TCM) for their reputed cognitive-enhancing effects (Howes and Houghton, 2003). 
The reputed effects of some traditional herbal drugs may not only be relevant in 
managing the cognitive decline that can be associated with general ageing but may 
also be relevant in the treatment of specific cognitive disorders such as AD (Perry et 
al., 2003). In Amazonian communities the use of traditional remedies prepared from 
Ptychopetaluin olacoides (Olacaceae) roots for treating various central nervous 
system conditions, including those associated with aging, was found to facilitate 
memory recovery (Siqueira et al., 2003). Monoterpenes and their derivatives were 
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found to be excellent inhibitors of AChE. Anticholinesterase activity of essential oils 
of Citrus paradisi (Miyazawa et al., 2001), Mentha species (Miyazawa et al., 1998) , 
and Salvia lavandulaefolia (Spanish sage) (Perry et al., 2002, Perry et al., 2003, 
Savelev et al., 2003) have been well established. Mechanisms of AChE inhibition by 
monoterpenoids have not been fully understood. However, several studies have 
considered them as reversible competitive inhibitors especially for AChE from 
Tribolium confusum and Rhizopertha domicia, but at relatively high concentrations 
of the terpenes (Greenberg-Levy et al., 1993). In contrast, Perry et al. (2002) found 
that these compounds are non-competitive reversible inhibitors for erythrocyte 
AChE. 
1.11.1 Libyan Medicinal plants 
In 2005 the World Health Organization (WHO, 2005) defined traditional 
medicine (TM) as " traditional medicine is a comprehensive term used to refer to 
both traditional medicine such as traditional Chinese medicine, Indian ayurvola and 
Arabic unani medicine, and to various forms of indigenous medicine". In Asia and 
Latin America the populations continue to use TM as a result of their historical 
circumstances and cultural beliefs. In China, TM accounts for around 40% of all 
health care needs, while in Africa, nearly 80% of the population uses TM to help to 
meet their health care requests (WHO, 2005). In Arabic countries in general, and 
particularly in Libya, there is a long history of people using herbs or plants to treat 
various diseases successfully (El Gadi, 1992, Kotb, 1983). Libya constitutes an apt 
example where medicinal plants are widely used in everyday life as a part of folk 
medicinal remedies. Here the traditional use of medicinal plants as spice, food, 
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flavours, etc., is becoming more and more popular. There are many traditional 
Libyan plants such as marjoram, sage, nigella, myrtle, thyme, absinthe, clove, oak, 
karkade, rosemary. These are the most popular plants, and account for approximately 
80% of the Libyan medicinal plants being used. Indeed, the extensive use of 
medicinal herbs has proven to be the most efficient traditional way of maintaining 
good health (Kotb, 1983). 
However, while some individual plant species such as Ginkgo biloba have been 
investigated in some detail (Sener et al., 2005, Stefanovits-Banyai et al., 2006, Das et 
al., 2002), there is relatively little knowledge and information available concerning 
the antioxidant potential and anticholinesterase activities of plant species in general 
and Libyan plants in particular. Considering the importance of these areas, selected 
medicinal plants which are being used traditionally in Libya for various disorders 
where free radicals are thought to be involved, were evaluated for their antioxidant 
and anticholinesterase activities. According to the traditional medicine uses the 
plants were extracted with water. The information on the plants that are used in this 
study is summarized in Table 1.5. Figure 1.2 illustrates the city names of Libya. 
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1.12 Aims and Objectives 
Plant extracts may have multiple pharmacological effects via a variety of 
mechanisms; the choice of plants investigated in this study was based on two criteria: 
first, in this domain there is no published study in Libya that deals with these plants, 
and the second criterion was that these plants have an ethnopharmacologically good 
reputation indicating their traditional utilization in the treatment of some abdominal 
diseases, and they have been proved to be efficient in the treatment of various 
disorders of the stomach, colon, rectum, oesophagus and liver. Furthermore, they 
have been described as treating hypertension and oedema, and as detoxicant, diuretic, 
or anti-inflammatory agents. Due to their traditional utilization and active 
components, these plants are also considered to be efficient for the treatment of free 
radical-related disorders. Therefore, the objectives of the current investigation were 
fourfold: 
Firstly, to screen plant extracts (cold water and boiled water extracts) for their 
antioxidant activity by three methods (FRAP, TEAC and DPPH assays) and to 
evaluate the relative level of antioxidant activity of these selected plants which are 
being used traditionally in Libya for various disorders where free radicals are thought 
to be involved. 
Plant phenolics comprise one of the major groups of primary antioxidants or free 
radical terminators. There are no publications on phenolic content and related 
antioxidant properties of the medicinal plants traditionally used in Libya. Therefore, 
it was reasonable to determine the total phenolic content in the selected plant 
extracts. Consquently the second goal of this study was to determine the phenolic 
contents of these selected plant extracts by the Folin-Ciocalteu method and to 
correlate or otherwise these contents with antioxidant activity. 
Thirdly, to determine the in vitro inhibitory potential of the selected plant extracts 
against AChE and BuChE by a modified Ellman's method, aiming to discover novel 
candidates for anticholinesterase compounds from natural resources. 
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Fourthly, to investigate the in vitro enzymatic digestion of the selected plant extracts 
in order to predict bioavailability of their effusions after ingestion. 
Xerophytes could reasonably be thought of as possible sources of known and novel 
antioxidants, sources conceivably richer than might be found in plants native to more 
mesic habitats. These plants are used in traditional medicine but may have other uses 
yet to be described in this comparatively little-known area of ethnobotany. 
Consequently, there has been an increased interest to discover and search for "new" 
compounds with an antioxidant potential from xerophytes. Therefore, a range of 
xerophytic species were assayed for their antioxidant and anticholinesterase 
activities. It is of interest to compare medicinal usage and chemical activity of this 
unrelated group of plants with those of Libyan origin. 
Finally, in the long term the data obtained here could be useful to develop an 
extended database regarding bioactivity of traditional herbal medicine plants of 
Libya and their correlations with various diseases and disorders. 
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Chapter 2 Screening of Antioxidant Activity of Selected 
Traditionally Used Libyan Medicinal Plant Extracts 
2.1 Introduction 
Reactive Oxygen Species (ROS) are highly reactive and potentially damaging 
transient chemical species created in all cells through various physiological and 
biochemical process (such as activation of phagocytes, mitochondrial respiration, and 
biosynthesis of endoperoxide) as undesirable metabolic by-products of normal 
aerobic metabolism (Rice-Evans and Miller, 1994, Parke et al., 1991, Rice-Evans, 
2000). Most ROS such as superoxide radical (0'-), hydroxyl radical (OH'), peroxyl 
radical (ROO' ), and nitric oxide radical (NO' ), attack biological molecules such as 
proteins, lipids, DNA and RNA leading to cell or tissue damage and injury associated 
with many diseases, from malignancy to cardiovascular disease and dementia (Rice- 
Evans and Parker 1998; Hashim et al., 2005). ROS are responsible in part for the 
ageing process finally leading to death. Parke (1999) has summarised the molecular 
mechanisms of ROS toxicity as: oxidation of vital thio-compounds to disulphate; loss 
of tissue GSH (glutathione); impairment of energy generation (ATP, NADH, and 
NADPH); oxidation of cytoplasm; inhibition of Ca 2+ transport and electrolyte 
homeostasis; DNA cleavage and the initiation and promotion of mutations and 
carcinogenesis. 
There are, however, many naturally occurring substances which function to 
protect against the potentially harmful effects of pro-oxidants. These substances, 
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termed antioxidants, are simply defined as "chemical compounds or substances that 
inhibit oxidation"(Balcerczyk and Bartosz, 2003). Antioxidant compounds must be 
present in biological systems in sufficient concentrations to prevent an accumulation 
of pro-oxidant molecules, a state known as oxidative stress (Buettner and Schafer, 
2000). Antioxidants can interfere with the production of free radicals and/or 
inactivate them once they are formed. In other words, these antioxidants can act by 
either interfering with the propagation stage of free radical generation itself or act 
directly as free radical scavengers. For example, vitamins E and C act as free radical 
scvengers which can quench free radicals as well as singlet oxygen (Rice-Evans and 
Miller, 1996). 
Currently used synthetic antioxidants have been suspected to cause or 
promote negative health effects (Amarowicz et al., 2004); hence stronger restrictions 
have been placed on their application. Therefore, there is a trend to substitute 
synthetic antioxidants with naturally occurring antioxidants. Some natural 
antioxidants such as rosemary, sage (Ollanketo et al., 2002) and Ginkgo biloba 
(Arredondo et al., 2004) are exploited commercially either as antioxidant additives or 
as nutritional supplements. The widespread uses of traditional herbs and medicinal 
plants have been traced to the occurrence of natural products with medicinal 
properties. Moreover, the role of herbal teas in disease prevention and cure has been 
attributed in part to antioxidant properties of their constituent lipo-soluble vitamins A 
and E, the water soluble vitamin C, and a wide range of amphipathic molecules, 
broadly termed phenolic compounds (Firuzi et al., 2005, Mello et al., 2005, Duan et 
al., 2006). 
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Phenolic compounds are commonly found in both edible and nonedible 
plants. They have been reported to have multiple biological effects including 
antioxidant activity (Ivanova et al., 2005, Kaur and Kapoor, 2002). Besides the well 
known and traditionally used natural antioxidants from tea (Mello et al., 2005), fruits 
(Prior, 2003, Velioglu et al., 1998, leong and Shui, 2002), vegetables (Gazzani et al., 
1998, Kaur and Kapoor, 2002) and spices (Owen and Johns, 2002) many other plants 
species (which are rich in phenolic content) have been investigated in search of novel 
antioxidants (Rosa et al., 2003, El-Ghorab et al., 2004, Hayder et al., 2004, Tepe et 
al., 2005b, Tepe et al., 2005a, Tepe et al., 2006, Tepe et al., 2004, Montoro et al., 
2005, Sun and Ho, 2005, Katalinic et al., 2006). 
During the last 20 years many publications have appeared on the 
measurement of antioxidants and a large number of different methods and strategies 
have been proposed and developed for the evaluation of the total antioxidant capacity 
in diverse samples such as biological samples, plant tissue and foodstuffs (Prior and 
Cao, 1999). Although there is a great multiplicity of methods used for antioxidant 
testing, none of them provides an ideal individual, approved, standardised reference 
method. This is simply because within biological systems, there are various sources 
of antioxidants including enzymes (such as superoxide dimutase, glutathione 
peroxidase and catalase), large molecules (like albumin and ferritin), small molecules 
(uric acid and polyphenols), some hormones (melatonin and estrogen) and dietary 
origin molecules such as vitamin C, carotenoids and flavonoids. On the other hand, 
both oxidants and antioxidants may have different chemical and physical features. 
Furthermore, antioxidants may respond in different manners to different radical or 
oxidant sources (Prior et al., 2005). 
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Consequently, in order to give an overall picture to describe the total 
antioxidant activity in any sample, more than one analytical assay must be applied 
(Frankel and Meyer, 2000). In general, most of the methods are based on the 
generation of the radical in the assay, and the antioxidant response in the sample 
against the radical is measured. However, the most widely and frequently used 
assays among these are ferric reducing antioxidant power (FRAP) (Benzie and 
Strain, 1996, Benzie and Strain, 1999) (µmol ferrous ion equivalents); Trolox 
equivalent antioxidant capacity, (TEAL) (Re et al., 1999) (mmol Trolox equivalents) 
and scavenging activity of 1,1'-diphenyl-2-picryl-hydrazyl (DPPH) radicals (Brand- 
Williams et al., 1995, Blois, 1958, Koleva et al., 2002) (mmol Trolox equivalents). 
The FRAP assay was first introduced by Benzie and Strain (1996,1999) for 
measuring the total antioxidant activity. The assay is based on the reducing power of 
a compound (antioxidant). A potent antioxidant will reduce the ferric ion (Fe3+) to 
the ferrous ion (Fe2+). The ferrous ion forms a blue complex (Fe2+/2,4,6-tripyridyl- 
s-triazine (TPTZ), which absorbs at 593 nm. A high absorbance at this wavelength 
indicates high reducing power of the phytochemical, thus high antioxidant activity. 
The TEAC assay (Re et al., 1999) is based on the relative ability of 
antioxidants to scavenge the radical cation 2,2'-azinobis3-ethylbenzothiazoline-6- 
sulphonate (ABTS+). The extent of quenching of the ABTS radical is measured 
spectrophotometrically at 734 nm and compared with Trolox, a water-soluble 
vitamin E analogue. 
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Radical scavenging activity using the DPPH method was described by Blois 
(1958). The essence of the DPPH method is that the antioxidant reacts with stable 
free radicals either by transferring electrons or hydrogen atoms to DPPH, thus 
neutralising free radical character (Naik et al., 2003). i. e., 1,1'-diphenyl-2-picryl- 
hydrazyl (deep violet colour) is converted to 1,1'-diphenyl-2-picryl-hydrazine 
(yellow). Therefore, the colour of the reaction mixture changes from deep violet to 
yellow and its absorbance at a wavelength of 517 nm decreases. The degree of 
discolouration indicates the scavenging potential of the sample antioxidant (Tsao and 
Deng, 2004, Abdille et al., 2005, Tepe et al., 2005a). These three methods are 
representative of the methods employing radicals in the evaluation of radical 
scavengers; such methods have gained high popularity over the last decade because 
of their rapidity and sensitivity (Katalinic et al., 2006). 
Recently, there has been an upsurge of interest in the therapeutic potential of 
traditional medicinal plants as antioxidants in reducing such free radicals induced by 
tissue injury. However, Mantle et al. (2000b) have determined the relative levels of 
endogenous antioxidant activity in a range of British medicinal plants selected on the 
basis of their widespread use in traditional herbal medicine including rosemary, sage, 
and mint. In Iran Souri et al. (2004) have screened sixty Iranian plants for their 
antioxidant activity. In addition, a large number of plants which have been used as 
food and medicinal herbs in Thailand (Chanwitheesuk et al., 2005), Bulgaria 
(Ivanova et al., 2005), Croatia (Katalinic et al., 2006), Tunisia (Bouzouta et al., 
2003), Spain (Navarro et al., 2003), China (Yingming et al., 2004), Turkey (Tepe et 
al., 2005a, Tepe et al., 2006), India (Jadhav and Bhutani, 2002) and Lithuania 
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(Dapkevicius et al., 1998, Miliauskas et al., 2004b) have been investigated for their 
antioxidant potential. 
Traditional medicine is widely practiced in Arabic countries in general, and 
particularly in Libya. Libya constitutes an apt example where medicinal plants are 
widely used in everyday life as part of folk medicinal remedies. 
Ethnopharmacological surveys conducted among herbal practitioners of traditional 
Arab medicine in these countries revealed a large number of indigenous plants are 
used as sources of their herbal therapies (Ali-Shtayeh et al., 2000). Some of these 
herbal therapies are used to treat diabetes, heart disease, high blood pressure, and 
liver disease, conditions in which oxidative stress is prominent (Kotb, 1983). At 
present, no laboratory data on the bioactivity of herbal medicines used to treat these 
diseases in traditional Arab medicine in Libya exist. 
Moreover, there is relatively little knowledge and information available 
concerning the antioxidant potential of plant species in general and in Libyan plants 
in particular. We hypothesized that the beneficial effects of these plants might be due 
to their antioxidant properties. Considering the importance of this area, the objective 
of this study is, therefore, to evaluate the relative level of antioxidant activity of 
selected medicinal plants which are being used traditionally in Libya for various 
disorders where free radicals are thought to be involved using the three different 
assays (FRAP, TEAC and DPPH). In the long term plants identified as having high 
levels of antioxidant activity in vitro may prove of value in the design of clinical 
trials of novel treatment in which free radical induced tissue damage has been 
implicated. 
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2.2 Materials and methods 
2.2.1 Plant materials: 
2.2.1.1 Plant collection and identification: 
The medicinal plant species used in this study (Table 1.5) were collected 
fresh from different areas of Libya, during the period from 12 `h April to 5 `h May 
2005. The green tea, clove and ginger roots were purchased from a local market for 
herbs in Benghazi. The botanical identification of the plant species was determined 
with the aid of descriptions given by Kotb (1983) and confirmed by Dr Osama 
Rahoma. The plant parts used were allowed to dry in air and then ground into a 
powder state using a commercial miller and finally used for the preparation of 
extracts within approximately one month of collection. 
2.2.1.2 Plant extract: 
Plant extracts with either hot or cold water (hot means freshly boiled water 
and cold means room temperature water) were prepared in triplicate in ways that 
mimic the traditionally used methods in folk medicine as follows. 
2.2.1.2.1 Hot water extract: 
One gram of each dried powdered plant was soaked with boiling de-ionized 
water (1: 20 w/v) in a conical flask and shaken for 30 minutes at 160 strokes per 
minute (IKA- VIBRAX-VXR, The Scientific Instrument Centre Ltd, Liverpool, UK). 
The extracts were filtered through glass wool then the filtrates were centrifuged 
(3000xg, 10 min) (Hettich Universal Centrifuge, Germany) to remove insoluble 
48 
matter, and the supernatants retained for antioxidant analysis (Koleva et al., 2002; 
Mantle et al., 2000b). 
2.2.1.2.2 Cold water extract: 
One gram of each dried powdered plant was soaked with de-ionized water 
(1: 20 w/v) in a conical flask and shaken for 24 hours at 160 strokes per minute (IKA- 
VIBRAX-VXR, The Scientific Instrument Centre Ltd, Liverpool, UK). The extracts 
were filtered through glass wool then the filtrates were centrifuged (3000xg, 10 min) 
(Hettich Universal Centrifuge, Germany) to remove insoluble matter, and the 
supernatants retained for antioxidant analysis (Koleva et al., 2002, Mantle et al., 
2000b). 
2.2.2 Chemicals: 
The chemicals used in these experiments, 2,2'-azinobis(3- 
ethylbenzthiazoline-6-sulfonic acid) powder (ABTS+), potassium persulphate, (+/-)- 
6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox), ferrous sulphate, 
ferric chloride, 2,4,6 tripyridyl-s-triazine (TPTZ), Folin-Ciocalteu reagent, gallic acid 
and 1,1'-diphenyl-2-picryl-hydrazyl (DPPH) were supplied by Sigma Chemical 
Company, UK. All other solvents, salts and reagents were obtained from VWR 
International, Country Durham, UK. 
49 
2.2.3 Antioxidant analysis: 
2.2.3.1 FRAP assay: 
The FRAP assay was originally developed by Benzie and Strain (1996) to 
measure reducing power in plasma, but the assay subsequently has also been adapted 
and used for the assay of antioxidants in botanical tissues. The reaction measures 
reduction of Fe3+ 2,4,6-tripyridyl-s-triazine (TPTZ) to Fe 2+ 2,4,6-tripyridyl-s-triazine 
(TPTZ), a coloured product. The assay solution was prepared fresh daily using 25 ml 
of 300 mM sodium acetate buffer pH 3.6 plus 2.5 ml of 10 mM TPTZ solution in 40 
mM HCl plus 2.5 ml of 20 mM ferric chloride (FeC13 6H20). A range of ferrous 
standard solutions (0 to 2 mM) were prepared from a stock 2 mM ferrous sulphate 
solution in distilled water. Absorbances were measured using a COBAS Mira (Roche 
Diagnostics, Welwyn Garden City, Herts. ). 10 µl of plant extract or standard solution 
was mixed with 30 µl de-ionized water as a diluter and 300 µl of the reactive solution 
and incubated for 250 s at 37°C. The change in absorbance at 600 nm over the 
incubation period was measured and the ferrous ion equivalent (FIE) unit of activity 
was calculated by comparison with a standard calibration curve of ferrous ions 
(figure 2.1). 
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Figure 2.1 FRAP Standard Calibration Curve. 
2.2.3.2 TEAC assay: 
00 
The standard TEAC assay described by Van den Berg et al. (1999) and Re et 
al. (1999) was used with minor modifications for the determination of TEAC values. 
This assay assesses the total radical scavenging capacity based on the ability of 
compounds to scavenge the stable ABTS radical (ABTS'). ABTS' (blue green) 
solution was produced by the reaction between one part of ABTS solution (7mM) 
and nine parts of potassium persulphate solution (2.45 mM) (both solutions were 
prepared in distilled water) in a total volume of 100m1. This radical solution was 
stored in the dark for 12-16 hours before use. The concentrated solution was diluted 
with phosphate buffered saline (PBS), pH 7.4 to give a final absorbance of 0.70 ± 
0.02 at 420 nm. The assay for the COBAS Mira was as follows: 5 µl of plant extract 
or Trolox standard and 10µl water were mixed with 500µ1 of ABTS' solution and 
incubated for 250s at 37°C. The change in absorbance at 405nm over the incubation 
period was measured. A range of Trolox standards (0-2.5 mmol) was prepared from a 
51 
stock Trolox solution in ethanol. The TEAC equivalent antioxidant was calculated by 
reference to the standard solution on a molar basis (figure 2.2). 
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Figure 2.2 TEAC Standard Calibration Curve. 
2.2.3.3 DPPH' assay: 
The original DPPH' (1,1'-diphenyl-2-picrylhydrazyl) method of Brand- 
William et al. (1995) was modified by Fukumoto and Mazza (2000). This method of 
Fukumoto and Mazza was further modified as follows: DPPH' (150 µM), a stable 
free radical, was dissolved in 80% (v/v) methanol. Using 80% (v/v) methanol had the 
advantage of a faster reaction rate for some compounds such BHA and lower 
evaporation losses. The assay was adapted to be carried out in the COBAS Mira. 10 
µl of plant extract or standard solution and 30 µl de-ionized water as a diluter were 
mixed with 300 µl of DPPH' solution and incubated for 25 min at 30°C. The change 
in absorbance at 500 nm over the incubation period was measured and compared to a 
standard calibration curve of Trolox standards (0 to 2.5 mmol in methanol; figure. 
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2.3). The TEAC of the antioxidant was calculated from standard Trolox solutions on 
a molar basis as shown in figure 2.3. 
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Figure 2.3 DPPH Standard Calibration Curve. 
2.2.4 Determination of total phenolic content: 
The total phenolic content of the plant extracts was determined according to 
the Folin- Ciocalteu method (Duan et al., 2006) with a slight modification. Instead of 
reading samples spectrophotometri cally the assay was performed in a Multiskan 
Ascent micro plate reader (Thermo Labsystem, Helsinki, Finland). In each well of a 
96-well flat-bottom polystyrene micro plate a 10 µl aliquot of plant extract or 
calibration standard was added to 130 t1 of Folin-Ciocalteu reagent (the concentrated 
commercial 2N reagent was diluted 1: 10 (v/v) with de-ionized water). After 5 min 
100 µ1 of 7.5% (w/v) sodium carbonate solution was added. The plates were shaken 
in the automated micro plate reader for lminute and incubated for 30minutes at 
37°C. The absorbance was measured at 750 nm, and then compared to a gallic acid 
53 
0 0.5 1 1.5 
calibration standard curve (0 to 1500 mg/L in de-ionized water) (figure 2.4). The 
total phenolic content was expressed as gallic acid equivalents (GAE) (figure 2.4). 
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Figure 2.4 Phenolic Content Standard Calibration Curve. 
The absorbances of the standard curves were plotted versus reference 
concentrations (ferrous sulphate conc. for FRAP and Trolox conc. for TEAC and 
DPPH). The absorbances of the test samples were read from the standard curve to 
give antioxidant activity as ferrous ion equivalent (FIE) for FRAP assay and as mmol 
Trolox equivalent for TEAC and DPPH assays (the data were corrected for any 
initial dilution of samples if required). Samples with high antioxidant activity need to 
be diluted for example, typically by 1: 5,1: 10, or 1: 20 before pipetting the sample 
into the assay tube. 
2.2.5 Statistical analysis: 
The experiments were carried out in triplicate extracts. The results are given 
as mean ± standard deviation (SD). The data for antioxidant activity for each assay 
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were analysed by one-way analysis of variance (ANOVA), and for comparison with 
green tea extract (standard antioxidant reference), the Dunnett's post-test was used 
which is designed to compare several treatments with one control treatment 
(Ljubuncic et al., 2005, Arredondo et al., 2004). A difference was considered 
statistically significant when p<0.05. All statistical tests were completed using 
Minitab version 14.0 and Microsoft Excel. Linear regressions between the content of 
phenolics and data for the antioxidant assays were assessed. 
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2.3 Results 
2.3.1 Antioxidant analysis: 
2.3.1.1 FRAP assay: 
In this study, the water phase antioxidant activity of plant extracts (hot and 
cold) produced from twenty three different Libyan plant species in comparison with 
the well established antioxidant properties of green tea have been investigated. As 
shown in Table 2.1 and Table 2.2 there were big differences in total antioxidant 
capacity for Ferric Reducing Antioxidant Power between the studied plants. The 
FRAP values varied from 748 to 40263 and 864 to 71010 (µmol Fee' E/g dried 
weight) for hot and cold water extracts, respectively. According to the comparison of 
reducing ability/antioxidant power of the green tea (standard antioxidant reference) 
with FRAP of the twenty three selected plant extracts, these plant extracts were 
divided into three groups (Table 2.3). Group (a) represented the plant extracts that 
shown high FRAP values as compared with the green tea (highly significant, p 
values ranged from less than 0.0001 to 0.05), group (b) moderate FRAP values 
(lower than the green tea), and group (c) low FRAP (lower than lmmol Fe 2+ E/g). 
Out of the twenty three selected plant extracts which were assayed for FRAP 
antioxidant activity, nine of the hot extracts and three of the cold extracts were found 
in the group of high antioxidant (group a) (Table 2.3). The group with moderate 
activity was represented by Teucrium polium> Hibiscus sabdariffa> Matricaria 
chamnomilla> Marrubiuin vulgare> Arteniisia absinthiinn> Phagnalon rupestre> 
Pituranthos tortousurs> Ruta graveolens> Urtica urens> Zingiber officinale> 
Raphanus raphanistrum for the hot extracts and Hibiscus sabdariffa> Calendula 
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o cinalis> Salvia officinalis>Rosmarinus officinalis> Teucrium poliuni> Thymus 
vulgaris> Olea europaea> Origanum majorana> Marrubium vulgare> Phagnalon 
rupestre> Nerium oleander> Ruta graveolens> Artemisia absinthium> Pituranthos 
tortousus> Raphanus raphanistruin> Matricaria chamomilla> Zingiber officiale> 
Urtica urens for the cold extracts. Urginea maritima and Alhagi maurorum 
represented the group with low antioxidant activity of both hot and cold water 
extracts (Table 2.3). Figure 2.5 and Table 2.4 illustrate the comparison of antioxidant 
activity for the hot and the cold water extracts assayed by the FRAP method. 
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Figure 2.5 FRAP assay of hot and cold water extracts 
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2.3.1.2 TEAC assay: 
The water phase antioxidant activities of hot and cold extracts produced from 
23 selected Libyan plants were studied in comparison with green tea, the established 
antioxidant reference. Measurement of antioxidant activity of these plant extracts by 
the TEAC assay showed a significant variation between studied species (Tables 2.1, 
2.2 and 2.3). The low antioxidant activity included Urginea maritima and Alhagi 
maurorum of both hot and cold plant extracts and Urtica urens of cold plant extract. 
Interestingly, Myrtus communis (hot and cold extracts) and Quercus robur and 
Syzygium aromaticum (cold plant extracts) exhibited high antioxidant potential 
compared to that of green tea (p value ranged between < 0.001 and < 0.05). Out of 
twenty three studied plant extracts a group of twenty (hot extracts) and seventeen 
(cold extracts) species were identified, with considerable (above 2 mmol) TEAC 
values ranging between 25.467 and 11.067 mmol T E, and between 10.833 and 2.053 
mmol TE of hot and cold extracts respectively. In general, the TEAC values of cold 
plant extracts were lower than those of hot extracts (figure 2.6 and Table 2.4). 
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Figure 2.6 TEAC assay of hot and cold water extracts. 
2.3.1.3 DPPH' assay: 
Results of DPPH reduction by hot and cold plant extracts are summarized in 
Tables 2.1,2.2 and Table 2.3. The results obtained show that the hot and cold 
extracts of Myrtus communis, Quercus robur and Syzygium aromaticum had a 
significant higher capacity of scavenging activity against the DPPH free radical (p 
<0.01,0.005, and 0.0001 of hot extracts respectively, and < 0.0001 of cold extracts ) 
than the green tea extract used as a standard (positive control). The hot extract of 
Salvia officinalis also showed activity against DPPH (19.533 mmol TO g) which 
was almost the same as those obtained from the green tea extract (19.433 mmol TO 
g). Nine hot and fifteen cold extracts exhibited low DPPH values below 2 mmol TE 
67 
which is considered as the group with a slight scavenging activity against the DPPH 
free radical. The remaining plant extracts showed a moderate scavenging activity 
with values ranging from 13.267 to 3.833 mmol TE /g and 5.156 to 2.155 mmol TE 
/g for hot and cold extracts respectively, in the following decreasing order: Olen 
europaea> Rosmarinus officinalis> Thymus vulgaris> Nerium oleander> Teucrium 
polium> Artemisia absinthium> Hibiscus sabdariffa> Matricaria chamomilla> 
Calendula officinalis> Marrubium vulgareh (hot extracts) and Hibiscus sabdariffa> 
Olea europaea> Phagnalon rupestre> Nerium oleander> Matricaria chamomilla 
(cold extracts). Generally, in this assay, the antioxidant values of hot extracts exhibit 
higher capacity of scavenging activity against the DPPH free radical as compared 
with the cold extract capacity (figure 2.7 and Table 2.4). 
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Figure 2.7 DPPH assay of hot and cold water extracts. 
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2.3.2 Phenolic content: 
The total phenolic content of the hot and cold plant extracts investigated in 
this study varied widely from 6937.5 to 267.0 mg GAE/ g of dry material and 6361.1 
to 248.0 mg GAE/ g of dry material for hot and cold extracts respectively (Table 2.1, 
2.2, and 2.3). Myrtus communis and Syzygium aromaticum of hot and cold extracts 
and Quercus robur hot extract presented the highest total phenol content as 
compared with the green tea (p <0.0001; figure 2.8 and Table 2.4). Correlation 
between the content of phenolic compounds and antioxidant activity was examined. 
Strong correlation between the total phenolic content and antioxidant capacity by 
FRAP assay was found in cold water extracts with correlation coefficient equal to 
0.972 (r2 = 0.95) (figure 2.9). As shown in figure 2.10 a positive relationship was 
also observed between total phenolic content and the TEAC assay result with 
correlation coefficient equal to 0.901 (r2 = 0.837) for cold extracts. Weak correlation 
was found between total phenolic content and the FRAP and TEAC assays for hot 
extracts with correlation coefficient equal to 0.376 and 0.505 (r2 = 0.143, r2 = 0.255) 
for FRAP and TEAC assays respectively. A positive correlation was obtained 
between the DPPH assay results and the total phenolic content in hot extracts with 
correlation coefficient equal to 0.813 (r2 = 0.661). Cold extracts showed a strong 
correlation between the content of phenolic compounds and DPPH with correlation 
coefficient equal to 0.915 (r2 = 0.837) (figure 2.11). In general, cold water extracts 
showed a stronger correlation between the phenolic content and total antioxidants for 
the three methods (FRAP, TEAC and DPPH) than hot water extracts. 
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2.4 Discussion 
In the present study twenty three medicinal plants were chosen native to the 
Libyan region traditionally used for the treatment of various disorders, where the free 
radicals are thought to be implicated. Based on the traditional way of ingestion of 
plant derived antioxidants it was appropriate to study the water-soluble antioxidant 
capacity and phenolic content of herbal teas prepared from Libyan medicinal plants. 
Plant extracts with either hot (freshly boiled water) or cold (room temperature water) 
were prepared simply in ways that mimic the traditionally used methods in folk 
medicine (Triantaphyllou et al., 2001). The extracts from these plants were screened 
for their antioxidant activity using the three most popular methods (FRAP, TEAC 
and DPPH). The results (Table 2.1,2.2,2.3,2.4) show that out of these twenty three 
extracts, the crude extracts (hot and cold) of M. communis, Q. robur and S. 
aromaticum exhibited the strongest antioxidant activity, in all tests used in this study 
(FRAP, TEAC and DPPH), and were higher than that of the positive control, green 
tea. Indeed, this suggests that for these extracts any of these methods will offer a 
reliable measurement of antioxidant status. Similar activities of M. communis 
extracts have been previously assessed by the linoleic acid assay (Rosa et al., 2003, 
Souri et al., 2004), the ß-carotene/ linoleic acid system and the DPPH free radical 
scavenging assay (Yadegarinia et al., 2006, Hayder et al., 2004). The results 
presented here were consistent with these reports. To the best of the knowledge of 
the author, no previous reports have dealt with M. communis antioxidant activity by 
FRAP and TEAC assays. The results obtained from S. aromaticum extracts in this 
study exhibited a high antioxidant activity which confirmed the existing literature 
using different antioxidant assays. S. aromaticum demonstrated a good degree of 
antioxidant capacity tested using the thiobarbituric acid reactive substance (TBARS) 
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and the ß-carotene agar assays (Lean and Mohamed, 1999, Dorman et al., 2000), the 
lipid / MA and aldehyde/ carboxylic assays (Lee, 2001); reductive potential, 
superoxide anion radical scavenging (Gulcin et al., 2004), TEAC (Juliani et al., 
2004 ) and DPPH free radical scavenging (Owen and Johns, 2002, Gulcin et al., 
2004, Nassar, 2006). No data have been found in the literature for the FRAP assay. 
Despite few reports in the literature regarding antioxidant activity of Q. robur bark 
(Andrensek et al., 2004), only one recent report has dealt with Q. robur fruit as a 
convenient nutritional source with antioxidant effects (Rakic et al., 2006). 
The results show that, in the experimental conditions described, most of the 
extracts possess moderate antioxidant capacity (especially the cold extracts) (figures 
2.5,2.6, and 2.7). Their behaviour differed according to the type of substrate in the 
assay and the temperature used for extraction. Accordingly, the differences in the 
activity of various extracts (the cold and the hot) can be explained by the loss of 
certain phytoconstituents (mainly polyphenols), probably because of the difference in 
temperature of the extraction procedures (Velioglu et al., 1998, Gazzani et al., 1998, 
Sun and Ho, 2005). In contrast, Zhou et al. (2000) and Katalinic et al. (2006) have 
suggested that a higher temperature promotes extraction of polyphenols and 
consequently free radical scavenging ability. On the other hand, at a higher 
temperature certain amounts of polyphenols may react with other components to 
produce an insoluble complex or may be oxidized (Vijayakumari et al., 1995). 
Preparation of plant inffusions with hot (100°C) and cold (25°C) water revealed that 
although antioxidants were liberated from leaves into the water at both the 
temperatures studied, infusions of hot water had higher antioxidant capacities as 
determined with FRAP. This notion was proposed when Melissae folium inffusions 
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were tested for their antioxidant capacity at different effusion temperatures by FRAP, 
TEAC and DPPH free radical scavenging (Katalinic et al., 2006). 
In this study, there was good agreement between the antioxidant activity 
(especially for FRAP assay) and the extraction method used in folklore for most 
plant species. For instance, N. oleander, M. chamomilla, T. vulgaris, S. officinalis 
and 0. europaea were suggested to be used as a hot infusion only in the traditional 
uses (El Gadi, 1992). Our results showed a higher antioxidant activity for those 
plants as hot extracts. Similarly, for those suggested to be used as cold infusions, 
such as Q. robur and S. aromaticum, the highest activities have been found in the 
cold extracts. 
Plant phenolics comprise one of the major groups of compounds of primary 
antioxidant or free radical terminators (Gao et al., 2000). In addition, numerous 
studies have suggested that the potent antioxidant activities of green tea (Rechner et 
al., 2002, Campanella et al., 2003) are due largely to its polyphenolic content. There 
are no publications on phenolic content and related antioxidant properties of the 
medicinal plants traditionally used in Libya; therefore, it was reasonable to determine 
their total phenolic content in the selected plant extracts. Phenolic content for these 
plant extracts were assayed by the Folin- Ciocalteu (F-C) method (Duan et al., 2006). 
The F-C method is actually not an antioxidant test but instead an assay for the 
quantity of oxidizable substances, i. e. phenolic compounds (Wangensteen et al., 
2004). Again, M. communis, Q. robur and S. aromaticum showed the highest 
phenolic content among the examined extracts (figure 2.8). The report by Romani et 
al. (2004) has offered quantitative and qualitative details of M. communis polyphenol 
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composition. Interestingly, they found that M. communis had the same main 
polyphenols that exist in green tea, such as galloyl derivatives, and this explained the 
high antioxidant capacity of M. communis. In addition, Abdel-Wahhab and Aly 
(2005) have demonstrated that the antioxidant capacity of S. aromaticum is due in 
part to the contribution of aromatic chemicals such as eugenol and eugenol acetate. 
The values of FRAP, TEAC and DPPH in the crude extracts (the cold) were 
highly correlated with the content of total phenolics (figures 2.9,2.10,2.11). In the 
results shown here the higher radical scavenging activity of the polar extracts 
confirms that the phenolic compounds are likely to contribute to the radical 
scavenging activity of these plants. According to Tepe et al. (2004) the presence of 
polar phenolics in the extracts is considered as an important factor in the free radical 
scavenging activity. These results from this experiment are in agreement with the 
literature (Gao et al., 2000, Arredondo et al., 2004, Tsai et al., 2002, Tepe et al., 
2004, Katalinic et al., 2006, Duan et al., 2006, Sun and Ho, 2005), which found a 
good correlation between antioxidant capacity (by FRAP, TEAC and DPPH) and 
phenolic contents. Furthermore, the correlation between total phenolic and ORAC 
values was previously reported by Velioglu et al (1998). In contrast, the previous 
report by Kahkonen et al. (1999) and Velioglu et al. (1998) did not show any 
correlation between total phenolic content and oxidation with the Mello assay. The 
difference between the results shown in this study and reports in the literatures could 
be explained by the difference in the procedure of the assays used. There are many 
investigations of antioxidant activity of medicinal plant extracts (Mantle et al., 1998, 
Mantle et al., 2000b, Souri et al., 2004, Chanwitheesuk et al., 2005, Ivanova et al., 
2005, Katalinic et al., 2006, Bouzouta et al., 2003, Navarro et al., 2003, Yingming et 
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al., 2004, Tepe et al., 2005b, Tepe et al., 2005a, Tepe et al., 2006, Kaur and Kapoor, 
2002, Dapkevicius et al., 1998, Miliauskas et al., 2004a, Miliauskas et al., 2004b). 
However, it is difficult to compare the results of these studies unless they are based 
on the same assay and extraction procedures. 
Antioxidant capacity estimation is assay dependent. The specificity and 
sensitivity of one method does not lead to complete examination of all phenolic 
compounds and antioxidants in the extracts. Therefore, a combination of several 
methods in vitro could provide a more reliable assessment of antioxidant activity. 
The FRAP assay is a method of antioxidant activity evaluation based on redox- 
reactions. It is quick and simple to perform and it is a reasonable screen for the 
ability to maintain redox status in cells or tissues. Reducing power appears to be 
related to the degree of hydroxylation and extent of conjugation in polyphenols 
(Zaporozhets et al., 2004). The FRAP mechanism measures electron transfer. 
However, it cannot detect compounds that act by radical quenching (hydrogen 
transfer), such as thiols and proteins (Prior et al., 2005). Thus it is helpful to use 
FRAP in combination with other methods. The TEAC assay gained popularity 
because it enables high-throughput screening on potential antioxidant capacity (Van 
den Berg et al., 1999, Re et al., 1999). This assay assesses the total radical 
scavenging capacity, based on the ability of a compound to scavenge the stable 
ABTS radical (Arts et al., 2004a, Arts et al., 2003, Arts et al., 2004b). The extracts 
that showed high TEAC values could contain substances that have a redox potential 
lower than that of ABTS'. Indeed, many phenolic compounds have low redox 
potential and can thus react with ABTS' (Frankel et al 2000; Prior et al 2005). The 
DPPH' system is a stable radical generating procedure. It can be used to assay a large 
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number of samples in a short period of time, and is sensitive enough to detect active 
compounds even at low concentrations and was used in the present study. In the 
DPPH' assay hydrogen -donating ability is an index of the primary chain-breaking 
antioxidant. These antioxidants donate hydrogen to free radicals which are then 
converted to non-radical species and thus inhibit the propagation phase of lipid 
peroxidation (Koleva et al., 2002, Apati et al., 2003). Consequently, the extracts that 
showed strong or remarkable activity against DPPH' free radical scavenging could 
have substances rich in available hydroxyl groups such as flavonoids. 
The results of the present work suggested that the efficacy of these plants 
could be explained, at least in part, by their antioxidant activity. These plants, rich in 
polar phenols, could be a good source of compounds that would help to increase 
overall antioxidant capacity of an organism and protect it against lipid peroxidation 
induced by oxidative stress. 
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Chapter 3 Acetylcholinesterase and butyrylcholinesterase 
inhibitory activity of some Libyan medicinal plants. 
3.1 Introduction 
Cholinesterases (ChE) are members of the serine hydrolase family, so named 
because they utilize a serine at the active site. Acetylcholinesterase (AChE) is 
distinguished from butyrylcholinesterase (BuChE) by its greater specificity for 
hydrolyzing acetylcholine (ACh), the cationic neurotransmitter (Quinn, 1987, 
Giacobini, 2004). ACh is involved in the signal transfer in the synapses. The ACh 
molecules are released from the presynaptic nerve in response to an action potential. 
They diffuse across the synapse and bind to the ACh receptor, which among other 
functions serves an ion gate for the entry of K+ into the postsynapse (Pope et al., 
2005). Under normal conditions, AChE rapidly and efficiently hydrolyzes ACh to 
acetic acid and choline. Extensive inhibition of this enzyme leads to accumulation of 
the neurotransmitter ACh and enhanced stimulation of postsynaptic cholinergic 
receptors. When the liberated ACh accumulates, they prevent the smooth 
transmission of nerve impulses across the synaptic gap at nerve junctions (Quinn, 
1987, Pope et al., 2005), and this causes loss of coordination, convulsion and 
ultimately death. Therefore, AChE is a key component of cholinergic brain synapses 
and neuromuscular junctions (Pope et al., 2005). Because of the essential role that 
AChE plays in the nervous system, this enzyme has long been an attractive target for 
the rational design of mechanism-based inhibitors (Giacobini, 2004). 
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Most uses of ChE inhibitors are based on a common mechanism of action 
initiated by inhibition of AChE. This action is beneficial in cases where a reduction 
in cholinergic transmission contributes to clinical symptoms, for instance, low 
muscle tone in the autoimmune disorder myasthenia gravis due to loss of nicotinic 
receptors (Pope et al., 2005, Taylor, 2001). Alzheimer's disease (AD) is the most 
common cause of dementia in the elderly population; it is a chronic, slowly 
progressive neurodegenerative disorder. The gradual loss of memory, decline in 
other cognitive functions and decrease in functional capacity results in death 
approximately 10 years after the onset of symptoms. In addition, AD is 
neuropathologically associated with a cholinergic deficiency. Therefore, ACh 
replacement therapy has been used as a potential strategy to improve AD pathology, 
mainly by inhibiting AChE (Ezoulin et al., 2005, Ferreira et al., 2006, Howes and 
Houghton, 2003). ChE inhibitors are the only class of compounds to date that have 
consistently proven to be efficacious in treating the cognitive and functional 
symptoms of AD (Fawcett et al., 2002, Schliebs et al., 1997, McQueen, 1995, 
Nagabukuro et al., 2004). It has been suggested that the inhibition of AChE and 
BuChE enzymes should be one of the objectives in the treatment of cognitive 
dysfunctions associated with AD (Giacobini, 2004, Okello et al., 2004). On this 
basis, the cholinergic hypothesis became the leading strategy for the development of 
drugs for the treatment of AD, even if today other approaches are also being 
followed in the search for agents able to treat and/or prevent the disease (Pope et al., 
2005, Giacobini, 2004, Furey et al., 2000). The medications that have been approved 
for the symptomatic treatment of mild to moderate AD are tacrine (an 
aminoacridine), donepezil (a benzylpiperi dine), rivastigmine (a carbamate) and 
galantamine (a tertiary alkaloid). Tacrine was the first AChE inhibitor to be launched 
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as a treatment for AD but, although there was evidence of beneficial effects on AD 
symptoms, the drug also caused showed several adverse side effects such as nausea 
and liver damage which in some cases made the usage of these drugs a serious 
problem (Orhan et al., 2004, Rampa et al., 2000, Knapp et al., 1994, Hu et al., 2005). 
Several plant species contain alkaloid cholinesterase inhibitors. For example, 
galantamine, an alkaloid from snowdrop (Galanthus nivalis) was recently approved 
for use in AD therapy (Howes and Houghton, 2003, Svedberg et al., 2004). 
Although plant alkaloids are best known for inhibiting cholinesterase 
enzymes, recent reports indicate new classes of cholinesterase-inhibiting 
phytochemicals such as terpenoids, especially monoterpenes (Perry et al., 2000, 
Perry et al., 2003, Greenberg-Levy et al., 1993) and coumarins (Howes and 
Houghton, 2003). The monoterpenes are amongst the most widespread and 
chemically interesting groups of natural products found in plants. They have been 
known for hundreds of years as components of the fragrant oils which can be 
obtained from leaves, flowers and fruits of many plants (Newman, 1972). The major 
commercially-obtained monoterpenes are able to inhibit human, bovine and electric 
eel AChEs (Savelev et al., 2003, Miyazawa et al., 2001, Miyazawa et al., 1998, Perry 
et al., 2000, Perry et al., 2002). 
In the last few years, much research has been carried out to evaluate the 
effectiveness and safety of the use of plants or their metabolites for the prevention or 
treatment of diseases. Consequently, screening of plant extracts represents a 
continuous effort to find new bioactive molecules or extracts and approximately 20% 
of the plants in the world or their extracts have been submitted to pharmacological or 
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biological tests. Several reports have been published on the biological effects of 
plants traditionally used either in infusion or in traditional remedies as cholinesterase 
inhibitors in vitro (Nagabukuro et al., 2004, Choudhary et al., 2005b, Perry et al., 
2000, Perry et al., 2002, Perry et al., 2003, Choudhary et al., 2005c, Zaheer ul et al., 
2003, Choudhary et al., 2005a, Okello et al., 2004). However, new naturally 
occurring anticholinesterases continue to be identified in a wide variety of medicinal 
plants from different countries, such as Turkey (Orhan et al., 2004, Tasdemir et al., 
2004); Portugal (Ferreira et al., 2006), New Zealand (Kellam et al., 1992), South 
Africa (Eldeen et al., 2005), Korea (Oh et al., 2004); China and India (Howes and 
Houghton, 2003). A recent study has reported that the extracts of Hypericum 
undulatum, Melissa officinalis, Laurus nobilis and Lavandula pedunculata showed 
high values for antioxidant and anticholinesterase activities (Ferreira et al., 2006). 
The main goal of the current study is to screen some recorded and unrecorded 
Libyan medicinal plants, particularly those which have different antioxidant 
activities (high to moderate or low), for possible anticholinesterase activity. The aim 
is also to introduce new plant sources whose biological activities as potential 
anticholinesteases have not been previously documented. Thus in the study reported 
in this chapter, the plant species Camellia sinensis; Myrtus communist Alhagi 
maurorum; Urginea maritima; Olea europaea; Matricaria chamomilla; Hibiscus 
sabdariffa; Quercus robur; Syzygium aromaticum; and Zingiber officinale, which 
have various ethnobotanical uses, were evaluated for their anticholinesterase 
activities. 
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3.2 Materials and methods 
3.2.1 Plant materials: 
3.2.1.1 Selection of the Plants 
The medicinal plant species used in this experiment were selected according 
to the results of the previous experiments reported in Chapter 2. According to 
antioxidant activity of the plants, they were divided into three categories: group (a), 
high antioxidant activity; group (b), moderate antioxidant activity and group (c), low 
antioxidant activity. Four plant species from group (a) Camellia sinensis; Myrtus 
communis; Quercus robur and Syzygium aromaticum, three from group (b) Olea 
europaea; Matricaria chamomilla and Hibiscus sabdariffa and three from group (c) 
Alhagi maurorum; Urginea maritima; Zingiber officinale were selected for this 
experiment. Details of these plants are presented in Table 1.5 (see Chapter 1) 
3.2.1.2 Plant extract: 
Plant extracts prepared with either hot or cold water (hot means freshly boiled 
water and cold means room temperature water) was prepared in ways that mimic the 
traditionally used methods in folk Libyan medicine as follows: 
3.2.1.2.1 Hot water extract: 
Four grams of each dried powdered plant were soaked in freshly boiled de- 
ionized water (1: 5 w/v) as described in section (2.2.1.2.1). 
3.2.1.2.2 Cold water extract: 
Four grams of each dried powdered plant was soaked with de-ionized water 
(1: 5 w/v) as described in section (2.2.1.2.2). 
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3.2.2 Chemicals: 
Acetylthiocholine iodide (ATChI), butyrylthiocholine iodide (BuTChI), 5,5f- 
dithiobisnitrobenzoic acid (DTNB), butyrylcholinesterase (BuChE, E. C. 3.1.18, from 
human serum), acetylcholinesterase (AChE, E. C. 3.1.1.7, from human erythrocytes) 
and sodium bicarbonate were purchased from Sigma Chemical Company, UK. 
Buffers and other chemicals were all of analytical grade. 
3.2.3 Anticholinesterase Assay: 
Anticholinesterase inhibition was determined spectrophotometri cally using 
the method described by Ellman (Ellman et al., 1961). The principle of this method is 
the measurement of the rate of production of the yellow coloured anion of 5-thio-2- 
thionitrobenzoic acid (TNB). The assay involves two linked reactions which produce 
the coloured compound (TNB): 
1- ATChI is hydrolysed enzymatically by acetylcholinesterase to give 
acetic acid and thiocholine. 
2- Thiocholine reacts with DTNB to produce TNB (yellow colour). 
The production of TNB is monitored by measuring the absorbance of light by the 
reaction mixture (maximum at 412nm) over the time. Any inhibition of AchE would 
result in reduction of hydrolysis by the enzyme and that would reduce the formation 
of the yellow anion. 
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The percentage of inhibition can be calculated as: 
(a-b)-(c-d) 
Inhibition (I %) = --------------------------x 100 
(a - b) 
Where: 
a= Buffer + substrate + enzyme + DTNB + de-ionised water (control) 
b= Buffer + substrate + DTNB + de-ionised water (blank) 
c= Buffer + substrate + enzyme + DTNB + sample (inhibitor) 
d= Buffer + substrate + DTNB + sample (colour control). 
In this experiment, a typical assay consisted of 5p1 of AchE solution at a final 
assay concentration of 0.03 U/mL or 5 µl of BuchE solution at a final assay 
concentration of 0.02 U/mL; 200 µ1 of 0.1 M sodium phosphate buffer (PB) pH 8.0; 
5 µl of DTNB at a final concentration of 0.3 mM prepared in 0.1 M PB pH 7.0 with 
0.12 M sodium bicarbonate and 5 µl of sample solution. The reactants were pre- 
incubated at 30°C for 15 minutes (for AChE) and 10 minutes (for BuChE) in a 96- 
well, flat bottom polystyrene microlitre plate. The reaction was initiated by adding 
5µl of ATChI or BuTChI at a final assay concentration of 0.5mM. A blank for each 
assay was prepared by replacing the 5µJ of enzyme with PB (pH 8) and 5 µl of the 
sample with de-ionised water. As a control 5 µl of the sample was replaced with de- 
ionised water. A colour control was assayed by replacing the 5µl of enzyme with PB 
(pH 8). Each sample was assayed in triplicate. For the assay absorbance was 
measured at 405nm in a Titertek Multiskan MCC/340 microplate reader for a period 
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of 6 minutes at 30°C with Genesis-Lite Windows microplate software (Labsystem 
International). 
3.2.4 Dose-response curves and equations: 
Each plant extract was tested over a range of concentrations. Each 
concentration was tested with triplicate extracts then by using Microsoft Excel 
software, straight line dose-response curves were fitted to the data points. The 
concentration of the plant extracts which gave 50% inhibition of the enzymes was 
expressed as an IC50 value. The activity of extracts which did not achieve 50% 
inhibition was expressed as the measured percent inhibition. 
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3.3 Results 
Results for the hot and the cold water extracts and their activities against 
AChE enzyme are presented in Table 3.1. An example of a dose response curve for 
the hot and the cold Camellia sinensis extracts against the AChE is shown in Figure 
3.1. There was a good agreement between the results obtained from the hot and the 
cold extracts against the AChE enzyme. Table 3.2 shows the results of hot and cold 
water extracts and their inhibitory activity toward BuChE. For the majority of plants, 
the hot water extracts exhibited higher activity against this enzyme than cold water 
extracts. However, the cold water extracts of M. chamomilla and Q. robur showed 
higher anti- BuChE activity. 
Most the plant extracts analyzed exhibited various inhibitory activities toward 
both enzymes. According to their activities, plant extracts were divided into four 
categories (Table 3.3). The first category includes the plants that did not show any 
inhibitory activities. The second category includes the plants that showed low 
activity (1- 25% inhibition); the third category contains the plants that exhibited 
moderate activity (25-50% inhibition) and the last category includes the plants which 
possessed high activity (50-100% inhibition). 
Some of the plant extracts such as Olea europaea which had no inhibitory 
activity against AChE (Table 3.1), exhibited low (22.63 ± 1.2 % at 0.12mg/ml in 
cold water extracts) and moderate (34.79 ± 0.38 % at 0.15mg/ml in hot water 
extracts) activity against BuChE (Table 3.2). Similarly, the extracts of Quercus robur 
which had lower activity against AChE showed much higher activity against BuChE 
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for both hot and cold water extracts. In contrast, the extracts of Urginea maritima 
(both in hot and cold water extracts) showed high activity (74.1 ± 0.77 %; 79.8 ± 
0.50 %) toward AChE. Both extracts had no noticeable activity against BuChE. On 
the other hand, while Matricaria chamomilla extracts appeared to possess no activity 
against AChE enzyme (Table 3.1), only the cold water extract displayed a noticeable 
inhibition with IC50 value of 0.109 ± 0.001 mg/ml against BuChE (Table 3.2). The 
lowest levels of activity were obtained from Zingiber officinale, Hibiscus sabdariffa 
and Alhagi maurorum extracts which showed negligible or no inhibitory activity 
against either enzyme (Table 3.3). The cold extract of Myrtus communis showed 
moderate activity against both enzymes, whereas the hot extracts exhibited good 
anti- BuChE activity with IC50 value of 0.148 ± 0.003mg/ml, and moderate (44.63 ± 
2 %) anti- AChE activity at a final concentration of 0.15mg/ml. Among the ten 
Libyan plants analysed, the green tea (Camellia sinensis) and clove (Syzygium 
aromaticum) were the most potent inhibitors against both AChE and BuChE 
enzymes. 
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Table 3.1. Inhibition of Human AChE enzyme by selected Libyan medicinal plants. 
Plant Scientific Name Hot Water Extracts Cold Water Extracts 
Camellia sinensis 
Myrtus communis 
Alhagi maurorum 
Urginea maritima 
Olea europaea 
Matricaria chamomilla 
Hibiscus sabdari ffa 
Quercus robur 
Syzygium aromaticum 
Zingiber officinale 
0.068 ± 0.001 a 
0.15 (44.63 ± 2) b 
0.172 c- 
0.200 ± 0.005 a 
0.148 c 
0.165 c 
0.279 c 
0.12 (15.80 ±0.97)b 
0.075 ± 0.003 a 
0.207 c 
0.070 ± 0.003 a 
1.31 (40.13 ± 0.90)b 
0.173 C 
0.114±0.002a 
0.118 C 
0.178 c 
0.295 C 
0.11 (34.37 ± 0.92)b 
0.088±0.001a 
0.110 C 
Data expressed as mean ± SD (n = 3) 
a= IC50 value (mg/ml) (final concentration of inhibitors required for 50% enzyme 
inhibition, as calculated from the dose response-curve equations). 
b= Concentration (mg/ml) providing this percentage inhibition (Inhibition %, 
inhibitory activity of extracts which did not reach 50% enzyme inhibition). 
c= No Inhibition at this concentration (mg/ml). 
1 
C 
O 
.r 
C 
0 
  Hot ext 
" Cold ext 
Figure 3.1 Dose response curve for the hot and the cold Camellia sinensis extracts 
against AChE. 
The graph was produced using Graphpad Prism to show the sigmoid pattern where 
concentrations are plotted on a logarithmic scale. 
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Table 3.2. Inhibition of Human BuChE enzyme by selected Libyan medicinal plants. 
Plant Scientific Name Hot Water Extracts Cold Water Extracts 
Camellia sinensis 
Myrtus communis 
Alhagi maurorum 
0.066 ± 0.004a 
0.148 ± 0.003a 
0.172 
0.12 (7.42 ± 0.46)° 
0.13 (38.74 ± 1.12)b 
0.17 (2.89 ± 0.21)b 
Urginea maritima 
Olea europaea 
Matricaria chamomilla 
Hibiscus sabdariffa 
Quercus robur 
Syzygium aromaticum 
Zingiber officinale 
0.33 (4.99 ± 0.68)b 
0.15 (34.79 ± 0.38) b 
0.165 c 
0.279 
0.066 ± 0.002 a 
0.116±0.007a 
0.207 c 
0.199 
0.12 (22.63 ± 1.2)b 
0.109±0.001a 
0.29 (21.68± 0.8)b 
0.055 ± 0.002' 
0.15 (44.7 ± 0.72)b 
0.110 
Data expressed as mean ± SD, (n = 3) 
a= IC50 value (mg/ml) (final concentration of inhibitors required for 50% enzyme 
inhibition, as calculated from the dose response-curve equations). 
b= Concentration (mg/ml) providing this percentage inhibition (Inhibition %, 
inhibitory activity of extracts which did not reach 50% enzyme inhibition). 
c= No Inhibition at this concentration (mg/ml). 
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3.4 Discussion 
Several studies have suggested that inhibition of cholinesterase is a promising 
approach for the treatment of Alzheimer's disease (AD) and for possible therapeutic 
applications in the treatment of Parkinson's disease, ageing, and myasthenia gravis 
(Atta-ur-Rahman et al., 2001). In all cases, the therapeutic strategy is to increase the 
persistence of synaptic ACh by blocking its degradation, such that there is a net 
increase in cholinergic receptor activation. This overall strategy is based on a clinical 
condition wherein activation of cholinergic receptors is deficient. Thus, increasing 
the residence of acetylcholine molecules within synapses by inhibiting AChE can at 
least partially counteract a deficiency in either the release of neurotransmitter or a 
reduction in cholinergic receptors/signalling. Traditional medicines have been widely 
used for a long time, and are still a vital source for the discovery of novel bio-active 
compounds. There is some evidence suggesting that butyrylcholinesterase activity 
may be involved in the pathogenesis of Alzheimer's disease. This has led to the 
hypothesis that the use of non-selective cholinesterase inhibitors that inhibit both 
butyrylcholinesterase and acetylcholinesterase may be more beneficial to patients 
with Alzheimer's disease than the use of selective cholinesterase inhibitors that 
inhibit acetylcholinesterase alone (Liston et al., 2004, Giacobini, 2004). In these 
experiments, the plant species of Camellia sinensis; Myrtus communist Alhagi 
maurorum; Urginea maritima; Olea europaea; Matricaria chamomilla; Hibiscus 
sabdariffa; Quercus robur; Syzygium aromaticum; and Zingiber officinale, which 
have various ethnobotanical uses, were examied for their anticholinesterase (AChE 
and BuChE) activities. The plant extracts used in this study, either hot (freshly boiled 
water) or cold (room temperature water), were prepared simply in ways that were 
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similar to the traditionally used methods in folk medicine (Triantaphyllou, et. al., 
2001). 
Tea belongs to the Theaceae family and is the most widely consumed beverage 
in the world next to water alone. Recent studies have shown that green tea possesses 
pharmacologically protective and biologically active properties such as 
anticarcinogenic (Borek, 2005), antioxidative and neuroprotective (Katalinic et al., 
2006, Beecher et al., 1999, Benzie and Szeto, 1999) activities. In this study, the IC50 
values for hot extracts of green tea (Camellia sinensis) (Table3.1) were 0.068 ± 
0.001mg/ml and 0.066 ± 0.004mg/ml. These results were higher than those of Okello 
et al (2004), who also found that green tea possesses potent inhibitory activities 
against AChE and BuChE enzymes with IC50 values of 0.05 ± 0.005 mg/ml and 0.05 
± 0.007 mg/ml, respectively. One chemical constituent which may cause this 
anticholinesterase activity in green tea has been suggested to be thymol (Duke, 
1992). Similar anticholinesterase activities were obtained from the hot extracts of S. 
aromaticum with IC50 of 0.075 ± 0.003 mg/ml and 0.116 ± 0.007 mg/ml toward the 
AChE and BuChE enzymes respectively. Although it was reported that S. 
aromaticum, among the clove species, has been successfully used to treat asthma as 
an antimicrobial against oral bacteria and various allergic disorders by oral 
administration (Gulcin et al., 2004), to the best of the knowledge of the author, no 
previous reports have dealt with S. aromaticum anticholinesterase activity. The low 
activity of the cold water extracts of green tea and clove against the BuChE enzyme 
could be due to the nature of the component which is responsible for this activity and 
the difference in temperature during the extraction procedures where the active 
component is not soluble until higher temperatures. The high and moderate activities 
92 
of extracts of M. communis could be explained by the presence of 1,8-cineole (Duke, 
1992), a monoterpene, that previously has been proven to be a cholinesterase 
inhibitor (Perry et al., 2000, Savelev et al., 2003, Greenberg-Levy et al., 1993, Perry 
et al., 2003, Miyazawa et al., 2001, Miyazawa et al., 1998). In this experiment, some 
extracts such as M. chamomilla and Q. robu, r which had lower activity against 
AChE, exhibited much higher activity against BuChE. In contrast, other extracts 
such as U. maritime possess high anti AChE activity and low anti- BuChE activity. 
These results are consistent with the recent report by Orhan et al. (2004), which also 
show differential activities for extracts from Turkish plants against the two enzymes. 
This might be due in part to the difference between the two enzymes genetically, 
structurally and in their kinetics (Giacobini, 2004) or could be because these plant 
extracts interact with the enzymes by different mechanisms (Orhan et al., 2004). 
Focusing on the possible correlations between antioxidant and 
anticholinesterase activities, a recent report has pointed out that the extracts of 
Hypericum undulatum, Melissa officinalis, Laurus nobilis and Lavandula 
pedunculata which showed high values for antioxidant activity also exhibited 
anticholinesterase activities (Ferreira et al., 2006). Excluding the U. maritime 
extracts, all the plant extracts that have been identified here to possess a noticeable 
inhibitory activity against either AChE or BuChE or both (excluding the U. maritime 
extracts) were found to have a potent antioxidant activity and presented in group (a) 
(Table 2.4, chapter 2). All the plant extracts screened herein showing high inhibitory 
activity (except the green tea) is reported here for the first time as cholinesterase 
inhibitors. In the light of these findings these plants could be considered for further 
studies in the treatment of AD. 
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Chapter 4 In vitro enzymatic digestion to predict apparent 
antioxidant and anticholinesterase release from selected Libyan 
medicinal plants. 
4.1 Introduction 
Plants play a major role in the introduction of new therapeutic agents and 
have received much attention as a source of biologically active substances such as 
antioxidant and anticholinesterase activities. Recently, there has been an upsurge of 
interest in the therapeutic potential of traditional medicinal plants as antioxidants in 
reducing free radicals induced by tissue injury. In addition, several classes of 
antioxidant dietary compounds have been suggested to present health benefits, and 
there is much evidence that consumption of these products leads to a reduction of the 
expression of various biomarkers of pro-inflammatory and /or oxidative stress (Silva 
et al., 2005). The active agents in these vegetative extracts are principally water- 
soluble or lipophilic antioxidant molecules. Indeed, most of these plant extracts 
contain various amounts of vitamin E, vitamin C, ß-carotene, and polyphenols 
including flavonoids (Zin et al., 2006, Chen et al., 2006, Anagnostopoulou et al., 
2006). Most phenolic compounds present in vegetables and fruits show beneficial 
physiological properties, e. g. cardioprotective, anticarcinogenic and anti- 
inflammatory activities, and, based on their ideal chemical structure for free radical- 
scavenging activities, they are reported to protect human health against oxidative 
damage. Phenolic compounds may also act as cardioprotective agents or at least they 
possess in vitro vasorelaxing effects and inhibit platelet aggregation (Amin et al., 
2006). In nature these compounds are normally present in plants as polymeric 
94 
complexes, which require to be degraded adequately before being absorbed (Serrano 
et al., 2005, Bourne et al., 1999, Capecka et al., 2005). 
Some of these antioxidant compounds can be inactivated and digested as they 
pass along the gastro-intestinal tract thus destroying the antioxidant and 
pharmacological properties of these molecules. These compounds may be degraded 
in the gastrointestinal tract and lose their activity even before absorption (Serrano et 
al., 2005). Nowadays, there is increasing information concerning absorption of 
phenolics and some of them have been detected in human plasma and other 
biological fluids (Bourne et al., 1999). Studies performed on rats and humans fed 
flavonols and catechins have confirmed that they are partly absorbed by the intestine 
(Martinez-Ortega et al., 2001). Furthermore, catechin was detected in human plasma 
after the intake of a diet containing fruits and vegetables. In the past, it was assumed 
that glycosylated forms of flavonoids were not absorbable from the digestive tract. In 
a human study with ileostomy subjects, however, it was found that the absorption of 
orally-administered quercetin was 24%, while the absorption of quercetin glycosides 
from onions was 52% (Hollman et al., 1995). In addition, rutin and other glycosides, 
such as phioretin, have been measured in the plasma of non-supplemented healthy 
volunteers (Paganga and Rice-Evans, 1997). 
Excessive or unregulated enzyme activities are implicated in a wide range of 
pathological conditions and control of these activities by administration of specific 
enzyme inhibitors has proven to be a viable means of their control. It has been 
suggested that the inhibition of AChE and BuChE enzymes should be one of the 
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objectives in the treatment of cognitive dysfunctions associated with Alzheimer's 
disease (AD) (Giacobini, 2004, Okello et al., 2004). On this basis, the cholinergic 
hypothesis became the leading strategy for the development of drugs to treat AD, 
even if today other approaches are also being followed in the search for agents able 
to treat and/or prevent the disease (Pope et al., 2005, Giacobini, 2004, Furey et al., 
2000). Although plant alkaloids are best known for inhibiting cholinesterase 
enzymes, recent reports indicate new classes of cholinesterase-inhibiting 
phytochemicals such as terpenoids, especially monoterpenes (Perry et al., 2000, 
Perry et al., 2003, Greenberg-Levy et al., 1993) and coumarins (Howes and 
Houghton, 2003). 
There is little information concerning the extent to which the antioxidant and 
the anticholinesterase compounds are absorbed in humans, their metabolism, 
pharmaco-kinetics and bioavailability. Although a small number of reports have 
provided evidence for uptake of specific flavonoids in rats (Ames et al., 1993, Verma 
et al., 1988), few studies have established flavonoid uptake in humans in vivo, and no 
publications regarding the digestion of antioxidant and anticholinesterase compounds 
from natural resources were found in the literature. Consequently, there is a need to 
elucidate the extent to which these compounds are absorbed and whether they are 
degraded or not in the intestinal tract (Serrano et al., 2007). Previously, such in vitro 
assays have been applied to compare the bioavailability of minerals from rich dietary 
sources such as tea (Powell et al., 1998). 
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Digestion is an initial step involving changes in pH and activity of proteolytic 
enzymes (Serrano et al., 2007). It would be interesting to evaluate possible changes 
in antioxidant properties and anticholinesterase activity of these plant extracts during 
digestion. According to their antioxidant activity, plants were divided into three 
categories: group (a), high antioxidant; group (b), moderate antioxidant and group 
(c), low antioxidant (see chapter 2). Four plant species from group (a) Camellia 
sinensis; Myrtus communis; Quercus robur and Syzygium aromaticum; three from 
group (b) Olea europaea; Matricaria chamomilla and Hibiscus sabdariffa, and three 
from group (c) Alhagi maurorum; Urginea maritima; Zingiber officinale were 
selected for experiments on antioxidant property changes during in vitro digestion. 
Only the plant extracts that showed acceptably high anticholinesterase activities were 
chosen for in vitro anticholinesterase release experiments (see chapter 3). The 
purpose of the present work was to ascertain if gastrointestinal conditions could 
affect the antioxidant properties of original plant extracts and evaluate their stability 
or possible transformation to other compounds during the in vitro digestion steps. 
The objective was to investigate whether in vitro bioavailability of these plant 
extracts could be used as a step prior to the evaluation of plant extracts in vivo. The 
aim was to use gastrointestinal fluids to mimic digestion and to qualify changes in 
apparent availability of antioxidant components and anticholinesterase active 
components from water-soluble extracts. 
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4.2 Materials and methods. 
4.2.1 Plant materials: 
4.2.1.1 Selection of the Plants 
The medicinal plant species used in this experiment were selected according 
to the results of previous experiments. According to antioxidant activity, plants were 
divided into three categories: group (a), high antioxidant; group (b), moderate 
antioxidant and group (c), low antioxidant. Four plant species from group (a) 
Camellia sinensis; Myrtus communis; Quercus robur and Syzygium aromaticum and 
three from (b) Olea europaea; Matricaria chamomilla and Hibiscus sabdariffa and 
(c) Alhagi maurorum; Urginea maritima; Zingiber officinale were selected for the 
experiments to measure antioxidant properties during in vitro digestion. Only the 
plant extracts that showed acceptable high anticholinesterase activity were chosen for 
in vitro anticholinesterase release experiments. Details of these plants are presented 
in Table 1.5. 
4.2.1.2 Plant extract: 
Plant extracts in either hot or cold water (hot means freshly boiled water and 
cold means room temperature water) were prepared in ways that mimic the 
traditionally used methods in Folk medicine as follows: 
4.2.1.2.1 Hot water extract: 
Four grams of each dried powdered plant was soaked in freshly boiled de- 
ionized water (1: 5 w/v) as described in the previous chapter (section 2.2.1.2.1). 
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4.2.1.2.2 Cold water extract: 
Four grams of each dried powdered plant was soaked with de-ionized water 
(1: 5 w/v) as described in the previous chapter (section 2.2.1.2.2). 
4.2.2 Chemicals: 
Acetylthiocholine iodide (ATChI), butyrylthiocholine iodide (BuTChI), 5,5'- 
dithiobisnitrobenzoic acid (DTNB), butyry1cholinesterase (BuChE. E. C. 3.1.18, from 
human serum), acetylcholinesterase (AChE, E. C. 3.1.1.7, from human erythrocytes), 
sodium bicarbonate, 2,2'-azinobis (3-ethylbenzthiazoline-6-sulphonic acid) powder 
ABTS+, potassium persulphate, (+/-)-6-hydroxy-2,5,7,8-tetramethyl-chroman-2- 
carboxylic acid (Trolox), ferrous sulphate, ferric chloride, 2,4,6 tripyridyl-s-triazine 
(TPTZ), 1,1'-diphenyl-2-picryl-hydrazyl (DPPH), pancreatin, and pepsin were 
purchased from Sigma Chemical Company, UK. Buffers and other chemicals were of 
analytical grade. All other solvents, salts and reagents were obtained from VWR 
International, Country Durham, UK. 
4.2.3 In vitro enzymatic procedure 
The in vitro digestion using sequential enzymatic steps is based on the method 
described by Aura et al. (1999) and recently modified by Nagah and Seal (2005). 
Briefly, one millilitre (for antioxidant experiments) and three millilitres (for 
anticholinesterase experiments) of the plant extract were added into a 50 millilitre 
plastic screw-topped tube containing five glass marbles. 19 ml of water was added 
only to the tubes used for antioxidant analysis. The tubes were incubated in a shaking 
water bath set at 37°C and at 120 strokes/ min. After 10 min, 10 ml of 0.05 M HCl 
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was added to each tube (simulating pH conditions in the stomach). After 20 minutes 
incubation, one mg pepsin dissolved in 0.5 ml of 0.05 M HCl was added. Then after 
further 20 min incubation, lml of 0.5M NaOH was added (simulating pH conditions 
in the small bowel). Finally, after 20 min, 5 ml of pancreatin (3 gram of pancreatin 
dissolved in 20m1 distilled water, centrifuged for 10minutes at 1500 xg and then 15 
ml of supernatant sufficient for three tubes, removed) was added and incubated for 
20 min. Each plant extract was run in triplicate. Aliquots of lml were taken from 
each tube immediately before each addition and stored at -20°C for antioxidant and 
anticholinesterase analysis. The digestion protocol is shown in figure 4.1. A blank 
was run in triplicate for each experiment to detect if the reagents themselves have 
any antioxidant or anticholinesterase activity. 
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lml of plant extract + 19 ml de-ionised water (antioxidant) 
Or 
3m1 of plant extract only (anticholinesterase) 
Incubation for 10 minutes in a 
shaking water bath set at 37°C 
and 120 strokes/min 
-lml, 10 min sample 
Add 10ml HCl (0.05M) 
Incubation for 20minutes 
-1 ml, 30 min sample 
Add 0.05m1 pepsin solution 
Incubation for 20minutes 
-1 ml, 50 min sample 
Add lml NaOH (0.5M) 
Incubation for 20minutes 
-lml, 70 min sample 
Add 5m1 pancreatin solution 
Incubation for 20minutes 
-lml, 90 min sample 
End of in vitro enzymatic digestion 
Figure 4.1 Protocol for the in vitro enzymatic method. 
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4.2.4 Sample analysis: 
4.2.4.1 Antioxidant analysis: 
The antioxidant assays (FRAP; TEAC and DPPH) were carried out using the 
COBAS Mira clinical analyser (Roche Diagnostics, Welwyn Garden City, Herts) as 
described previously in sections 2.2.3.1,2.2.3.2 and 2.2.3.3, respectively. 
4.2.4.2 Anticholinesterase analysis: 
This assay was preformed using a Titertek Multskan MCC/340 microplate 
reader. The procedure was as described previously in section 3.2.3. 
4.2.5 Statistical analysis 
The change of antioxidant and anticholinesterase release for the plant extracts 
during the enzymatic incubation steps was assessed by the differences between 10 
and 90 minutes of enzymatic incubation for each sample individually using paired - 
sample `t-tests'. A significance level of 0.05 was used for each test. All statistical 
tests were completed using Microsoft Excel. 
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4.3 Results 
4.3.1 Antioxidant analysis: 
4.3.1.1 FRAP assay 
The pattern of antioxidant release for the tested plant extracts (hot and cold), 
green tea, Myrtus communis, Quercus robur, Syzygium aromaticum, Olea europaea, 
Matricaria chamomilla, Hibiscus sabdariffa, Alhagi maurorus, Urginea maritima, 
Zingiber officinale through the whole in vitro procedure determined using the FRAP 
assay is shown in figure 4.2. There was a significant decrease in the total apparent 
antioxidant capacity at the end of the enzymatic digestion (after 90 min) as compared 
with the first step (after 10 min) for green tea (A, p=0.0001, both hot and cold), M. 
communis (B, p=0.003, p=0.0001), Q. robur (C, p=0.01, p=0.0002), S. 
aroaticum (D, p=0.0006, p=0.004), 0. europaea (E, p=0.001, p=0.02), M. 
chamomilla (F, p=0.0006 hot only) and U. maritima (I, p=0.004, p=0.01). The 
apparent antioxidant content of H. sabdariffa and A. maurorus extracts (hot and cold) 
appeared to increase at the end of the digestion step (after 90 min), although this 
increase was not statistically significant (figure 4.2, G and H). In contrast, the 
extracts of Z. officinale showed a decrease in the total apparent antioxidant capacity 
at the end of enzymatic digestion, although the decrease was not significant (figure 
4.2, J). Generally, most of the changes in the total antioxidant capacity during the 90 
minutes occurred after addition of the sodium hydroxide (NaOH) i. e. when the pH 
changed from acidic to alkaline (figure 4.2). 
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4.3.1.2 TEAC assay 
The pattern of antioxidant release for the ten plant extracts examined through 
the whole in vitro procedure determined using the TEAC assay is shown in figure 
4.3. The increase in the total antioxidant release was statistically significant during 
the 90 minutes of the enzymatic digestion for most samples tested by this method 
including green tea (A, p=0.01, hot only), M. communis (B, p=0.0003, p=0.004), 
Q. robur (C, p=0.008, cold only), S. aromaticum (D, p=0.00006, p=0.00008), M. 
chamomilla (F, p=0.05, p=0.006), H. sabdariffa (G, p=0.007, p=0.0007), A. 
maurorus (H, p=0.05, p=0.01), U. maritima (I, p=0.003, p=0.001) and Z. 
officinale (J, p=0.0001, p=0.005 hot and the cold). In contrast, the hot extract of 0. 
europaea showed a significant reduction in the total antioxidant capacity at the end 
of the enzymatic digestion with p- value less than 0.001, while the apparent 
antioxidant content of the cold extract appeared to be significantly increased at the 
end of the digestion steps (p = 0.0007) (figure 4.3, E). Interestingly, it is of note that 
the plant extracts with low antioxidant activity (group c), showed TEAC values 
which remained almost constant during the first four steps of the digestion then 
significantly increased after the addition of pancreatin solution (last step of the 
digestion) (figure 4.3, H, I and J). The plant extracts with high antioxidant activity 
(group a) exhibited sharp increases in the antioxidant capacity after adding HCl 
solution. In general, there was a decrease in the apparent antioxidant capacity after 
adding the NaOH solution (figure 4.3). 
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4.3.1.3 DPPH assay 
The pattern of antioxidant release for the ten plant extracts examined through 
the whole in vitro procedure determined using the DPPH assay is shown in figure 
4.4. There was a significant increase in the total apparent antioxidant capacity for hot 
and cold extracts of green tea (A, p=0.0001,0.0008), M. communis (B, p=0.003, p 
< 0.006), Q. robur (C, p=0.03, cold only), S. aromaticum (D, p<0.007, C only), M. 
chamomilla (F, p=0.05,0.03), A. maurorus (H, p=0.02, p<0.01), U. maritima(I, p 
= 0.01, < 0.004) and Z. officinale (J, p=0.007, cold only) at the last step of the in 
vitro enzymatic digestion. The scavenging activity of the hot and the cold water 
extracts of H. sabdariffa and 0. europaea against DPPH radicals showed a constant 
pattern during the digestion steps except the final panceatin step where the DPPH 
values of the hot extract of 0. europaea was significantly decreased (E, p=0.008), 
while the DPPH value of the hot extract of H. sabdariffa was increased, although this 
increase was not statistically significant (Figure 4.4, E and G). 
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4.3.2 Anticholinesterase analysis: 
The pattern of anti-BuChE activity for green tea (A) and Q. robur (B) 
extracts and anti-AChE activity for Urginea maritima (A) and Syzygium aromaticum 
(B) extracts through the whole in vitro procedure are shown in figure 4.5 and figure 
4.6 respectively. The results show the gradual decrease of the inhibition of human 
BuChE enzyme activity during the enzymatic steps for green tea (from 89.95 to 
20.54 %) and Q. robur extracts (from 89.04 to 15.52% and from 88.12 to 17.80 % 
for hot and cold extracts respectively) (figure 4.5, A and B). In contrast to these 
results, the inhibition activity against BuChE enzyme completely disappeared 
following the addition of HCl solution (the second step of the digestion) for all the 
remaining samples tested (results not shown). Similarly, most of the plant extracts 
that were tested against AChE showed no activity after adding HCl solution (M. 
communis the hot and the cold extracts and the hot extract of green tea) or NaOH 
solution (the cold extract of green tea) (results not shown). Exceptions to this are 
shown in figure 4.6. The inhibition activity of the hot and the cold extracts of U. 
maritima during the enzymatic steps was more varied and showed a sharp decrease 
in the inhibition activity after adding HCl solution (from 83.33 to 12.77 % and from 
83.10 to 37.16% for hot and cold extracts respectively) (Figure 4.6, A). The activity 
then increased after adding NaOH solution (from 9.44 to 48.97 % and from 41.21 to 
69.59 % for hot and cold extracts respectively) and finally the activity decreased 
again at the last step (figure 4.6, A). The S. aromaticum extracts exhibited a gradual 
decrease in the inhibition activity during each step of in vitro digestion (figure 4.6, 
B). 
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4.4 Discussion 
Intensive research has been conducted over the last 10 years to promote the 
antioxidant nutritional medicine in therapeutic fields. Plant extracts now known to 
have antioxidant activities were traditionally used to strengthen the natural immune 
defenses. The protective effects of diets rich in fruit and vegetables against 
cardiovascular disease and certain cancers have been attributed partly to the 
antioxidant vitamins and carotenoids contained therein (Serrano et al., 2005). Recent 
work is beginning to highlight the potential role of the phenolic components of fruit, 
vegetables, beverages and grains. The flavonoids, phenylpropanoids and phenolic 
acids present in these foods and drinks may act as antioxidants, or may act in 
combination with other constituents such as glucosinolates, indoles, dithiolthiones, 
and isothiocyanates. These agents may constitute alternative mechanisms that may 
contribute to the anticarcinogenic or cardioprotective actions. Many in vitro studies 
demonstrate the free radical scavenging properties of dietary phenolic 
phytochemicals. These valuable compounds might be destroyed in the 
gastrointestinal tract and lose their activity even before they are absorbed. In the 
present work, the medicinal plant species were selected in accordance with the 
results of the previous experiments (Chapter 2 and Chapter 3). According to the 
antioxidant activity of the plants, they were divided into three categories: group (a), 
high antioxidant; group (b), moderate antioxidant and group (c), low antioxidant. 
Four plant species from group (a) Camellia sinensis; Myrtus communis; Quercus 
robur and Syzygium aromaticum and three from (b) Olea europaea; Matricaria 
chamomilla and Hibiscus sabdariffa and (c) Alhagi maurorum; Urginea maritime 
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and Zingiber officinale were selected for the experiments of antioxidant release 
during in vitro digestion. Only the plant extracts that represented acceptable high 
anticholinesterase activity were chosen for in vitro antiochinesterase release 
experiments. 
Within biological systems there are various sources of antioxidant including 
enzymes (such as superoxide dimutase, glutathione peroxidise and catalase), large 
molecules (like albumin and ferritin), small molecules (uric acid and polyphenols), 
some hormones (melatonin and estrogen) and molecules of dietary origin such as 
vitamin C, carotenoids, flavonoids, etc. Furthermore, both oxidants and antioxidants 
may have different chemical and physical features and antioxidants themselves may 
respond in different manners to different radical or oxidant sources. Consequently, 
the use of more than one assay (FRAP, TEAC and DPPH) to assess the antioxidant 
activity is appropriate. In addition, these assays themselves are sensitive and 
responsive to different antioxidant molecules. Thus in a complex system (such as the 
digestive tract or blood) a combination of different assays should provide a balanced 
evaluation of antioxidant capacity or potential. 
As shown in figure 4.2 the apparent antioxidant remained constant under 
acidic conditions and following partial protein hydrolysis then decreased under the 
alkaline conditions. This shows that the stability of some phenolic compounds is 
highly influenced by the pH and the intestinal medium produces considerable 
changes. These results were consistent with those reported by Martinez-Ortega et al. 
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(2001) and Serrano et al. (2001,2007). This means that potentially most antioxidants 
would be available in the first stage of the digestion process, and numerous studies 
have shown that the bioavaliability of bioaccessible antioxidant in the small intestine 
can be very low, for instance, for polyphenols (Clifford, 2004) and for ß- carotene 
(Serrano et al., 2005, Granado et al., 2006, Novotny et al., 2005, McDougall et al., 
2005). In the case of H. sabdariffa and A. maurorus extracts (hot and cold) the 
increased FRAP values at the end of the digestion step (after 90 minutes) (figure 4.2, 
G and H) could be explained by the ability of plant phenols to complex with protein 
by hydrogen bonding and the subsequent release of these antioxidants during protein 
hydrolysis (Duodu et al., 2003, McDougall et al., 2005). In general, the initial release 
of antioxidant in water confirms the presence of water soluble compounds which are 
probably in a free form within these extracts. 
In contrast, the results obtained by the TEAC assay (figure 4.3) and the 
DPPH assay (figure 4.4) showed significant release of antioxidant capacity at the 
final step of the in vitro digestion procedure (after 90 min) in most extracts tested. 
Many flavonoids occur in plants in the glycosidic form and need to be heated with 
HCI to release the free flavonoids (Harborne, 1984). For instance, there are more 
than a hundred different glycosides of quercetin alone which have been described. In 
addition, it was clearly demonstrated that some polyphenols are normally only 
detected after acid or alkaline hydrolysis of plant tissue (Harbome, 1984). This could 
explain the high release of antioxidant capacity after addition of the HCl in all plant 
extracts with high antioxidant activity (group a) (figure 4.3, A, B, C and D and figure 
4.4, A, B, C and D). On the other hand, the plant extracts representing the moderate 
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and low antioxidant activity (group b and c) exhibited approximately the same 
pattern in the increased release of antioxidant activities (which was constant during 
the acidic conditions, partial protein hydrolysis and under the alkaline conditions) 
after the addition of pancreatin. This suggests that some antioxidants may have been 
bound or associated with the carbohydrate fraction of the soluble plant material and 
there is the potential for the release of antioxidants and increased availability for 
absorption in different regions of the intestine as well as providing protection from 
oxidative damage within the gut lumen and intestinal mucosa itself (Nagah and Seal, 
2005, Serrano et al., 2007, Record and Lane, 2001). In general, the results suggest 
that the variation in antioxidant activity detected by the three assays are due to the 
structure and chemistry of the individual polyphenols, their ability to chelate metal 
and scavenge free radicals as well as the chemistry involved in the antioxidant 
analysis. No data has been found in the literature regarding the in vitro digestion of 
these plant extracts tested herein (except for green tea) (Record and Lane, 2001). 
Thus this is the first report and there is, therefore, scope for much further 
investigation of these plant species. 
Numerous plants and their constituents with pharmacological activity that are 
traditionally used for the treatment of cognitive disorders including 
anticholinesterase have been reviewed (Howes and Houghton, 2003, Perry et al., 
2003, Howes et al., 2003). Plant alkaloids such as galantamine are best known for 
inhibiting cholinesterase enzymes. However, recent publications demonstrate new 
classes of cholinesterase-inhibiting phytochemicals such as terpenoids, especially 
monoterpenes such as 1,8-cineole and camphor (Perry et al., 2000, Perry et al., 2003, 
Greenberg-Levy et al., 1993) and coumarins (Howes and Houghton, 2003). Such 
findings indicate that plants may yield novel ChE inhibitors from these classes. It is 
121 
well established that in the majority of cases alkaloids contain at least one nitrogen 
atom. The compounds are generally basic, and this means that salt formation can 
occur in the presence of acidic conditions. However, the use of very low pH such as 
in the stomach may result in hydrolysis of ester groups if these are present in the 
alkaloids. This could explain the loss of inhibitory activity of most of the plant 
extracts against human AChE and BuChE enzymes during the in vitro digestion 
procedure. For example, as shown in Figure 4.5 and Figure 4.6 the inhibition 
activities were gradually decreased after addition of the HC1 solution (i. e. at the 
acidic conditions). To the best of the knowledge of the author, there are no previous 
reports dealing with anticholinesterase activity of plant extracts during in vitro 
digestion. 
In summary, these plants are rich in interesting mixtures of polar polyphenols 
with potential antioxidant activity. Some of these plant extracts proved to be resistant 
to gastrointestinal treatment and released more antioxidants. The apparent variation 
in the stability of these extracts under gastrointestinal conditions seems to be highly 
depending on the nature and chemistry of the polyphenols that exist in the extract. 
The anticholinesterase data indicate that these plant extracts are very susceptible to 
digestive proteolysis and therefore they do not display any activity against human 
AChE and BuChE enzymes. Further detailed studies including fractionation, 
biochemical analysis, toxicity and metabolism are needed to better evaluate the 
potential use of these extracts. 
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Chapter 5 Screening of antioxidant and anticholinesterase 
potential of selected traditionally used cacti and succulents. 
5.1 Introduction 
Cacti are a group of plants found in habitats which experience regular dry 
periods and make up a coherent botanical family, the Cactaceae (Haustein, 1991). 
Typical cacti are xerophytes, mostly with succulent columnar or spherical stems 
bearing leaves which are rudimentary or modified into spines, and areoles, which are 
modified side shoots found in the leaf axils and are diagnostic structures for the 
family. The Cactaceae are an almost exclusively American taxon with a centre of 
distribution in Mexico, and are found as far north as Canada and south as Patagonia. 
A few epiphytic cacti have been found in Africa, but these are generally believed to 
have arrived there as a result of human or animal activity (Rowley, 1978). 
Xerophytes (cacti and other succulent plants) are found in regions such as 
mountains, deserts, semi-deserts and and scrublands which feature a definite dry 
season during which the plant becomes dormant. Time and the ecological changes 
which have driven the evolution of xerophytes have resulted in such plants having a 
range of structural and temporal features which enable them to utilize habitats of 
high environmental stress. Most cacti grow in areas with low rainfall, long dry 
periods and intense sunlight. Certain highly characteristic adaptations make it 
possible for them to endure these extreme environmental conditions without damage 
(Rowley, 1978). 
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Adaptations observed in xerophytes to the pressures of harsh, seasonally and 
environments include morphological adaptations to accommodate water-storage 
tissues and reduced surface to volume ratios of the plants, seen in the thickened 
globular or thick columnar habits of many xerophytes. Particularly cacti possess a 
great reduction in the number of stomata in the epidermis as compared with 
mesophytic species. In addition, many other adaptations are found such as the 
recessing of stomata or development of coverings of hair or scales by stomata 
(resulting in decreased water loss). Also secretion of waxes by the outer epidermis, 
absence of leaves or their reduction to spines (which act as condensation foci and 
deter herbivores) and Crassulacean acid metabolism (CAM) which enables the plants 
to fix carbon at night when water loss can be minimised are considered as potential 
mechanisms to survive (Haustein, 1991, Rowley, 1978). 
A small number of species of cacti are used in traditional Native American 
medicine systems as pain killers, especially for the skin to treat bums and other 
wounds, where they are thought to be able to speed up the healing process and 
reduce the infection risk, and as ritual intoxicants and hallucinogens ('entheogens') 
(Wu et al., 2006). Numerous cacti contain a variety of alkaloids. In addition, an 
effective heart stimulant is extracted from the stems of Selenicereus grandiflorus and 
used mainly in England and North America (Haustein, 1991). Furthermore, their 
juices are used as beverages or used in food flavourings and colouring (Kuti, 2004). 
It is well established that Aloe vera extracts possess different biological activities 
such as anti-inflammation, anti-cancer, anti-diabetes and macrophage activation 
(Reynolds and Dweek, 1999). Cactus pear fruits (Opuntia ficus-indica) attract great 
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interest because of their nutritional and antioxidant properties (Kuti, 2004). A recent 
study has confirmed the antioxidant properties of Aloe vera (Wu et al., 2006). 
Interest in antioxidants has grown during the late 20th and early 21st 
centuries because of their putative anti-ageing properties and the needs of industries 
which use natural products and to prolong storage times and shelf-lives of their 
products. Xerophytes could reasonably be thought of as possible sources of known 
and novel antioxidants; sources conceivably richer than might be found in plants 
native to more mesic habitats. These plants may have other uses yet to be described 
in this comparatively little-known area of ethnobotany. Consequently, there has been 
an increased interest to discover and search for "new" compounds with an 
antioxidant potential from natural sources. Therefore, a range of xerophytic species 
(Senecio saginata, Echinocereus cucumis, Ephedra nootkatensis, Opuntia stricta, 
Euphorbia mammillaris and Euphorbia inermis) were assayed for their antioxidant 
and anticholinesterase activities. 
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5.2 Materials and methods 
5.2.1 Plant materials: 
5.2.1.1 Plant collection and identification: 
The plant species used in this experiment (Table. 5.1) were obtained from the 
permanent plant collection of Moorbank Botanical Garden, University of Newcastle 
upon Tyne, UK and verified by Dr G. Wake. 
5.2.1.2 Plant extract: 
Plant extracts in either hot or cold water (hot means freshly boiled water and 
cold means room temperature water) were prepared as follows: 
5.2.1.2.1 Hot water extract: 
One gram of each fresh shoot material was homogenised (ULTRA- 
TURRAX® T25 basic, IKA O-Werke) with boiling de-ionized water (1: 20 w/v) in a 
conical flask and shaken for 30 minutes at 150 strokes per minute (Grant Instruments 
Cambridge Ltd, Cambridge, UK). The extracts were filtered through Whatman filter 
papers (1 circle 70mm 0) then the filtrates were centrifuged (2500xg, 10 min) 
(Mistral 3000i centrifuge, MSE scientific Instruments, Crawley, UK) to remove 
insoluble matter, and the supernatants retained to be used for antioxidant and 
anticholinesterase analysis 
5.2.1.2.2 Cold water extract: 
One gram of each fresh shoot material was homogenised (ULTRA- 
TURRAX® T25 basic, IKA°-Werke) with cold de-ionized water (1: 20 w/v) in a 
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conical flask and shaken for 24 hours at 150 strokes per minute (Grant Instruments 
Cambridge Ltd, Cambridge, UK). The extracts were filtered through Whatman filter 
papers (1 circle 70mm 0) then the filtrates were centrifuged (2500xg, 10 min) 
(Mistral 3000i centrifuge, MSE scientific Instruments, Crawley, UK) to remove 
insoluble matter, and the supernatants retained for antioxidant and anticholinesterase 
analysis. 
Because natural drying takes so long, weighed fresh material was used for 
extraction and a weighed small sample of tissue was freeze dried to constant weight 
giving a dry weight. This was used to calculate the dry weight of the tissue used in 
extract preparations. 
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5.2.2 Chemicals: 
The chemicals used in these experiments, acetylthiocholine iodide (ATChI), 
butyrylthiocholine iodide (BuTChI), 5,5'-dithiobisnitrobenzoic acid (DTNB), 
butyrylcholinesterase (BuChE. E. C. 3.1.18, from human serum), acetylcholinesterase 
(AChE, E. C. 3.1.1.7, from human erythrocytes), sodium bicarbonate, 2,2-azinobis (3- 
ethylbenzthiazoline-6-sulphonic acid) powder ABTS+, potassium persulphate, (+/-)- 
6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox), ferrous sulphate, 
ferric chloride, 2,4,6 tripyridyl-s-triazine (TPTZ), 1,1'-diphenyl-2-picryl-hydrazyl 
(DPPH) were purchased from Sigma Chemical Company, UK. Buffers and other 
chemicals were of analytical grade. All other solvents, salts and reagents were 
obtained from VWR International, Country Durham, UK. 
5.2.3 Sample analysis: 
5.2.3.1 Antioxidant analysis: 
The antioxidant assays (FRAP, TEAC and DPPH) were carried out using the 
COBAS Mira clinical analyser (Roche Diagnostics, Welwyn Garden City, Herts), as 
previously described in chapter 2 sections 2.2.3.1,2.2.3.2,2.2.3.3, respectively. 
5.2.3.2 Anticholinesterase analysis: 
This assay was preformed using a Titertek Multiskan MCC/340 microplate 
reader. The procedure was previously described in 3.2.3. 
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5.2.4 Statistical analysis: 
The experiments were carried out in triplicate. The results are given as mean 
± standard deviation (SD). The data of antioxidant activity for each assay were 
analysed by one-way analysis of variance (ANOVA), and for comparison with green 
tea extract (standard antioxidant reference), the Dunnett's post -test was used which 
is designed to compare several treatments with one control treatment (Ljubuncic et 
al., 2005, Arredondo et al., 2004). A difference was considered statistically 
significant when p< 0.05. All statistical tests were completed using Minitab version 
14.0 and Microsoft Excel. 
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5.3 Results 
5.3.1 Antioxidant analysis: 
5.3.1.1 FRAP assay 
In this study, the water phase antioxidant activity of plant extracts (hot and 
cold) produced from different cacti and succulents in comparison with the well 
established antioxidant properties of green tea was tested. As shown in Table 5.2 and 
Table 5.3, the FRAP values varied from 855 to 170569 and 572 to 145147 (µmol 
Fe 2+ E/g dried weight) for hot and cold water extracts, respectively. The hot and cold 
extracts of Euphorbia mammillaris showed very high FRAP values as compared with 
green tea (highly significant, p values less than 0.0001), fourteen and three times 
higher for hot and cold extracts respectively (figure 5.1). The Echinocereus cucumis 
extracts exhibited moderate activity with FRAP values of 10860 and 41982 (µmol 
Fe2+ E/g dried weight) for hot and cold extracts respectively. The remaining plant 
extracts (hot and cold) measured by this method showed a low activity. 
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FRAP assay of hot and cold water extracts 
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Figure 5.1 FRAP assay of hot and cold extracts. 
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5.3.1.2 TEAC assay 
The water soluble antioxidant activities of hot and cold extracts produced 
from the selected cacti and succulents were studied in comparison with green tea, the 
established antioxidant reference. The results obtained by this assay are summarised 
in Table 5.2 and Table 5.3, and figure 5.2. The antioxidant power of cold extracts of 
Euphorbia mammillaris was found to be higher than that of green tea (p< 0.0001), 
while the hot extract of this cactus exhibited a TEAC value (39.06 mmol Trolox E/g) 
which was almost the same as that obtained from the green tea (39.46 mmol Trolox 
E/g). Both extracts of Echinocereus cucumi exhibited moderate ABTS scavenging 
potential, although this potential was not as high as that for green tea (figure 5.2). 
Low antioxidant activities (values lower than 7 mmol Trolox E/g), were determined 
for the remaining plant extracts. 
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Figure 5.2 TEAC assay for hot and cold plant extracts. 
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5.3.1.3 DPPH assay 
Results of DPPH reduction by extracts are shown in Table 5.2 and Table 5.3. 
As can be seen in figure 5.3, the cold extracts of Euphorbia mammillaris and 
Echinocereus cucumi exhibited high DPPH radical scavengening activities which 
were significantly higher than that of the positive control (p<0.0001). The hot 
Euphorbia mammillaris and Echinocereus cucumis extracts also showed moderate 
scavenging activities against the DPPH free radical (18.50 and 11.92 mmol TO g, 
respectively) as compared with the green tea (19.43 mmol TO g) (figure 5.3). The 
remaining plant extracts showed a slight scavenging activity against the DPPH free 
radical with values ranged from 2.61 to 6.64 mmol TE /g and 2.70 to 7.62 mmol TE 
/g for hot and cold extracts respectively. 
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Figure 5.3 DPPH assay for hot and cold extracts. 
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5.3.2 Anticholinesterase analysis: 
The inhibitory activities of hot and cold extracts of selected cacti and 
succulents were tested against both AChE and BuChE enzymes. None of the plant 
extracts tested showed inhibitory activity against either enzyme (results not shown). 
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5.4 Discussion 
Extremes of temperature, harsh soil chemistry alone or in combination with 
osmotic effects caused by water insufficiency might reasonably be expected to result 
in promotion of undesirable protoplasmic chemistry events such as molecular 
breakage and generation of reactive free radicals at high rates. Therefore, strong 
defence systems are expected to exist in xerophytes to deal with such events and 
conditions. Such enhancement could reasonably be imagined to include high- 
activities of systems which deal with problems such as DNA repair, photorespiration, 
wound repair, and neutralisation of oxidative free-radicals. 
In this study, six medicinal cacti and succulent species (Senecio saginata; 
Echinocereus cucumis; Ephedra nootkatensis; Opuntia stricta; Euphorbia 
mammillaris and Euphorbia inermis) with traditional uses for the treatment of 
various disorders, where the free radicals are thought to be implicated were 
investigated. The extracts from these plants were screened for their antioxidant 
activity using the three most popular methods (FRAP, TEAC and DPPH) which had 
been used previously in this thesis in the assessment of medicinal plants of Libyan 
origin. The results (Table 5.2,5.3) show that of these extracts, the crude extracts (hot 
and/or cold) of E. cucumis and E. mammillaris exhibited the highest antioxidant 
activity in all assays used in this study (FRAP, TEAC and DPPH). As shown in 
figure 5.3, the cold extracts possessed higher activity than those obtained using hot 
water. The differences in the activity of these extracts (the cold and the hot) can be 
explained by the loss of certain phytoconstituents which are probably because of the 
difference in temperature of the extraction procedures (Velioglu et al 1998; Gazzani 
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et al 1998; Sun & Ho 2005), and possible breakdown or chemical modification of 
these compounds during the intial extraction with boiling water. Furthermore, the 
length of the extraction process could be considered as a critical factor in explaining 
possible differences between the results of hot and cold extracts. The hot extraction 
is a much shorter extraction, so although there is potential for rapid solubilisation, 
thereafter the plant material is only in the water for short time (30 min). In contrast, 
the cold extraction leaves the material in the water for a long time (24 h). This may 
mean that eventually even poorly soluble materials may be extracted from the plant 
material. In another words, the soaking temperature and soaking time that were 
applied for these extract preparation have a vital effect on antioxidant activities of 
these cacti. Similarly, a previous study by Zhou et al. (2000) showed that antioxidant 
activities of teas are highly dependent on their soaking temperature and time. 
Low antioxidant activities of the remaining plant extracts could be explained 
by the following reasons. Firstly the plants used in this study were grown at 
Moorbank Botanical Garden and they might not have been exposed to high stress 
levels which would be found in the wild environment as described in the introduction 
(section 5.1). Secondly they are perhaps healthy plants and may not need to produce 
high antioxidant levels. Finally the extraction procedure of water-heavy tissues may 
not be ideal. Rather than looking for reasons that perhaps the antioxidant activity of 
cacti was suppressed in some way, an alternative hypothesis could be that cacti do 
not produce antioxidants which can be detected by the FRAP, TEAC or DPPH 
methodology as perhaps they do not, after all, produce antioxidants in high 
quantities. The results were consistent no matter which assay was employed (FRAP, 
TEAC and DPPH). This is an interesting observation as most plants previously tested 
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showed varying antioxidant activities depending upon the assays used (Katalinic et 
al., 2006, Miliauskas et al., 2004a, Serrano et al., 2007, Nagah and Seal, 2005). For 
example, Miliauskas et al. (2004b) showed that extract of Echinacea purpurea 
exhibited apparently higher antioxidant capacity using the ABTS test than when the 
same extract was assayed using DPPH assay. 
Although the cacti contain a lot of alkaloids they did not show any inhibitory 
activities either against human AChE or against BuChE enzymes. There appears to 
be no direct correlation between antioxidant and anticholinesterase activities in cacti. 
These results are consistent with those of Godkar et al. (2006), who reported that 
seed oil of Celestrus panicultus exhibits a potent antioxidant capacity in the DPPH 
assay and showed no inhibitory activity against AChE at all. This will be discussed 
further in the general discussion (section 6). 
In conclusion, the data on extraction procedures and antioxidant activity 
assessement obtained in these experiments single out E. cucumis and E. mammillaris 
as the most promising sources of natural antioxidants. Purification and identificaltion 
of the active compounds in these cacti is required for a better understanding of the 
protective mechanisms involved and for possible thereapeutic application. 
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Chapter 6 General Discussion 
Free radicals can be defined as any molecules or molecular fragments which 
contain one or more unpaired electrons (Halliwell et al., 1995, Halliwell and 
Gutteridge, 1999, Parsons, 2000, Halliwell, 2000). These molecules of unpaired 
electrons usually confer a considerable degree of reactivity upon free radicals. Those 
derived from oxygen represent the most vital class of such species generated in living 
systems (Valko et al., 2006). Reactive Oxygen Species (ROS) are highly reactive and 
potentially damaging transient chemical species created in all cells through various 
physiological and biochemical process (such as activation of phagocytes, 
mitochondrial respiration, and biosynthesis of endoperoxide) as undesirable 
metabolic by-products of normal aerobic metabolism (Rice-Evans and Miller, 1994, 
Parke et al., 1991, Rice-Evans, 2000). In addition to ROS from endogenous sources, 
ROS can also be produced by a host of exogenous processes such as environmental 
agents (pollutant gases) (Scott, 1997, Valko et al., 2006). Free radicals have the 
potential to damage intracellular organelles and components such as nucleic acids, 
lipids and proteins on which normal cell function depends. Free radical oxidation 
damages the outer membrane of a cell, and then continues into the cell where DNA 
and intracellular molecules may be affected. Thus, if the damage is to DNA, any 
damage to the cell will be replicated each time during cell division (Valko et al., 
2004, Halliwell and Gutteridge, 1999, Hillestrom et al., 2006). Molecular 
mechanisms of ROS toxicity are mainly through oxidation of vital thio - compounds 
to disulphate, loss of tissue GSH (glutathione), impairment of energy generation 
(ATP, NADH, and NADPH), oxidation of cytoplasm, inhibition of Ca 2+ transport 
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and electrolyte homeostasis, DNA cleavage and the initiation and promotion of 
mutations and carcinogenesis (Parke, 1999). 
Research in recent years has shown the importance of ROS in degenerative 
processes related to aging (Ames et al., 1993) and diseases such as coronary heart 
disease, chronic renal failure, diabetes mellitus, immune dysfunction, atherosclerosis, 
cancer and neurodegenerative disorders such as Parkinson's and Alzheimer's 
diseases (Halliwell, 1994, Arts and Hollman, 2005, Ames, 1983, Arredondo et al., 
2004, Young and Woodside, 2001, Halliwell, 1996, Halliwell, 2002, Halliwell et al., 
1992, Chisolm and Steinberg, 2000, Morello et al., 2002, Basu et al., 1999, Wiseman 
and O'Reilly, 1997, Vanharanta et al., 2003). 
Exposure to free radicals from internal and external sources has led 
organisms to develop a series of biological defence mechanisms against oxidative 
damage induced by ROS (Valko et al., 2007). The biological defence systems 
involve preventative mechanisms, repair mechanisms and physical defences. These 
mechanisms are dependent upon antioxidants. Antioxidants can be defined as "any 
substance which when present at low concentrations compared with those of an 
oxidizable substance, significantly delays or prevents a pro-oxidant initiated 
oxidation of that substrate" (Halliwell, 1995, Kumaran and Joel Karunakaran, 2007). 
Thus antioxidants play the housekeeper's role, "mopping up" free radicals before 
they get a chance to cause injury. Under normal physiological conditions, there is a 
balance between both the activities and intracellular concentration of antioxidants. 
However, cellular injury resulting from the imbalance between the free radical 
generating and scavenging system resulting in "oxidative stress", has been implicated 
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in the pathogenesis of a variety of disorders. Among the complex array of 
endogenous defences are radical scavenging proteins, enzymes, numerous 
endogenous antioxidant factors which include coenzyme Q, glutathione (GSH) and 
other tissue thiols, metal ion sequestering proteins such as oxidizing (Fe2+) to (Fe 3+), 
ROS metabolising enzymes such as superoxide dismutase, and catalase. In addition, 
there are other important antioxidant compounds including a-tocopherol (vitamin E), 
ascorbic acid (vitamin C), uric acid, and the histidine- containing dipeptides 
carnosine and anserine (Hussin et al., 2007). Besides these compounds, there are a 
variety of plant-derived dietary compounds which act as antioxidants such as 
carotenoids and flavonoids (Prenesti et al., 2007, Montoro et al., 2005, Yu et al., 
2005). 
Antioxidant activity cannot be measured directly but rather by the effects of 
antioxidants in a reaction medium in controlling the extent of oxidation. A wide 
range of methods using this principle are currently used to assess antioxidant 
capacity in food, botanicals, nutraceuticals and other dietary supplements. Although 
there is a great multiplicity of methods used for antioxidant testing, none of them 
provide an ideal individual, approved, standardized reference method, as both 
oxidants and antioxidants may have different chemical and physical features. 
Furthermore, antioxidants may respond in different manners to different radical or 
oxidant sources (Prior et al., 2005). In general, most of the methods are based on the 
generation of the radical in the assay and the antioxidant response in the sample 
against the radical is measured. Antioxidant capacity estimation is assay dependent. 
The specificity and sensitivity of one method does not lead to complete examination 
of all phenolic compounds and antioxidants in the extracts. Therefore, a combination 
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of several methods in vitro provides a more reliable assessment of antioxidant 
activity. The most widely and frequently used assays among these are ferric reducing 
antioxidant power (FRAP) (Benzie and Strain, 1996, Benzie and Strain, 1999) (pmol 
ferrous ion equivalents); Trolox equivalent antioxidant capacity (TEAL) (Re et al., 
1999) (mmol Trolox equivalents) and scavenging activity of diphenyl-2- picryl- 
hydrazyl (DPPH) radicals (Brand-Williams et al., 1995, Blois, 1958, Koleva et al., 
2002) (mmol Trolox equivalents). 
The FRAP assay is a method of antioxidant activity evaluation based on 
redox reactions. It is quick and simple to perform and it is a reasonable screen for the 
ability to maintain redox status in cells or tissues. Reducing power appears to be 
related to the degree of hydroxylation and extent of conjugation in polyphenols 
(Zaporozhets et al., 2004). The FRAP mechanism measures electron transfer. 
However, it cannot detect compounds that act by radical quenching (hydrogen 
transfer), such as thiols and proteins (Prior et al., 2005). Thus it is helpful to use 
FRAP in combination with other methods. The TEAC assay gained popularity 
because it enables high-throughput screening on potential antioxidant capacity (Van 
den Berg et al., 1999, Re et al., 1999). This assay assesses the total radical 
scavenging capacity, based on the ability of a compound to scavenge the stable 
ABTS radical (Arts et al., 2004a, Arts et al., 2003, Arts et al., 2004b). The DPPH' 
system is a stable radical-generating procedure. It can be used to assay a large 
number of samples in a short period of time, and is sensitive enough to detect active 
compounds even at low concentrations and thus it was used in the present study. In 
the DPPH' assay hydrogen-donating ability is an index of the primary chain- 
breaking antioxidant. These antioxidants donate hydrogen to free radicals which are 
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then converted to non-radical species and thus inhibit the propagation phase of lipid 
peroxidation (Koleva et al., 2002, Apati et al., 2003). In the results presented in this 
thesis, there were clear differences in appearent antioxidant capacities for the same 
samples when measured using different assay systems. Whilst, in many cases the 
relative responses were similar (i. e. high FRAP values correlated with high TEAC 
values) this was not always the case. This study, therefore, indicates that it is 
important to meaure the antioxidant activity by using various radicals and oxidation 
systems and to take into account both antioxidant and phenolic contents while 
evaluating the antioxidant potential of plant extracts. The model system consisting of 
a combination of FRAP, TEAC and DPPH assays can, however, be used to screen 
large number of sources for their antioxidant capacity because of the relatively rapid 
through put of samples. Nevertheless, it is important to use an in vivo methodology 
to assess the real potential of an antioxidant to protect cells. Consequently, the 
present work should be complemented with further investigations. 
Herbal medicine still represents a very important phenomenon in traditional 
cultures. However, the use of pharmaceutical products of plant origin is a growing 
area in the treatment of several illnesses and competes with popular medicine in 
many cultures. Furthermore, medicinal plants represent a vast role in the introduction 
of new therapeutic agents and have received much attention as a source of 
biologically active substances including antioxidants and anticholinesterase. 
Therefore, medicinal plants continue to be subjected to extensive screening 
worldwide in an attempt to develop and identify antioxidative and anticholinesterase 
compounds and this has become an important issue for pharmaceutical industries 
worldwide. 
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In the first experiments, twenty three medicinal plants, native to the Libyan 
region and traditionally used for the treatment of various disorders where free 
radicals are thought to be implicated were chosen. The plants tested and their 
medicinal uses are shown in Table 1.5 (Chapter 1). Based on the traditional way of 
ingestion of plant- derived antioxidant it was appropriate to study the water-soluble 
antioxidant capacity and phenolic content of herbal teas prepared from these Libyan 
medicinal plants. Plant extracts with either hot (freshly boiled water) or cold (room 
temperature water) were prepared simply in ways which mimic the traditionally used 
methods in Folk medicine (Triantaphyllou et. al., 2001). The extracts from these 
plants were screened for their antioxidant activity using the three most popular 
methods (FRAP, TEAC and DPPH). 
The results (Table 2.1,2.2,2.3,2.4, Chapter 2) show that out of these twenty 
three extracts, the crude extracts (hot and cold) of M. communis, Q. robur and S. 
aromaticum exhibited the strongest antioxidant activity in all tests used in this study 
(FRAP, TEAC and DPPH) and were higher than that of the positive control, green 
tea, a product for which there is an extensive literature showing antioxidant and 
anticholinesterase properties. This suggests that for these particular extracts any of 
these methods will offer a reliable measurement of antioxidant capacity. On the basis 
of the results of this study, it is clear that these plant extracts have powerful 
antioxidant activity against various antioxidative systems in vitro. Moreover, these 
plants can be used as easily accessible sources of natural antioxidants for use as 
possible supplements or in a pharmaceutical application. The extracts that showed 
high TEAC values could contain substances that have a redox potential lower than 
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that of the marker radical ABTS'. Indeed, many phenolic compounds have low redox 
potentials and can thus react with ABTS' to remove the singlet electron (Frankel et al 
2000; Prior et al 2005). 
Numerous studies have suggested that the potent antioxidant activities of 
green tea (Rechner et al., 2002, Campanella et al., 2003) are due largely to the 
polyphenolic content of the leaves. Consequently, it was reasonable to determine the 
total phenolic content in the selected Libyan plants. Again, M. communis, Q. robur 
and S. aromaticum showed the highest phenolic content among the examined 
extracts (figure 2.8, Chapter 2). In addition, the values of FRAP, TEAC and DPPH in 
both the crude extracts (the cold and the hot) were highly correlated with the content 
of total phenolics. The results from these experiments are consistent with previous 
reports in the literature (Gao et al., 2000, Arredondo et al., 2004, Tsai et al., 2002, 
Tepe et al., 2004, Katalinic et al., 2006, Duan et al., 2006, Sun and Ho, 2005). These 
authers found a good correlation between antioxidant capacity (by FRAP, TEAC and 
DPPH) and phenolic contents. For many extracts, phenolic compounds appear to be 
responsible for the antioxidant potential. In this sense, these plants rich in mixtures of 
polar phenols with potential antioxidant activity possibly provide a clue for the 
discovery of new therapeutic strategies in pathologies associated with oxidative 
stress- induced cell damage. In the case of phenolic compounds, the ability of the 
phenolics to act as antioxidants depends on the redox properties of their phenolic 
hydroxyl groups, which allow them to act as reducing agents, hydrogen-donated 
antioxidants or oxygen quenchers (Rice-Evans and Miller, 1996). 
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From the results of the antioxidant studies plant extracts were categorized as 
(a) high antioxidant activity, (b) intermediate activity and (c) low antioxidant activity 
(see Table 2.4, Chapter 2). Four plants from group (a), three plants from group (b) 
and three plants from group (c) were selected for further studies. These plants and 
their categories are shown in Table 6.1. 
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Cholinesterases (ChE) are members of the serine hydrolase family, so named 
because they utilize a serine at the active site. According to substrate specificities and 
susceptibility to inhibitors, this group of enzymes is divided into two major 
categories. The first category is plasma butyrylcholinesterase (BuChE) pseudo, or 
type II cholinesterase (Quinn, 1987, Godkar et al., 2006). This enzyme is found 
principally in plasma and it acts on a variety of choline phenyl, nitro phenyl and 
other types of esters. The second category is acetylcholinesterase (AChE), which is 
also called "red cell", true, specific or type I cholinesterase. AChE exists primarily in 
nerve cells and muscular junctions but it is also found in other neural and non neural 
cells. AChE is distinguished from BuChE by its greater specificity for hydrolyzing 
acetylcholine (ACh), the cationic neurotransmitter (Quinn, 1987, Giacobini, 2004). 
AChE plays an important role in terminating the nerve impulse in the cholinergic 
synapses by hydrolysis or breakdown of Ach into acetic acid and choline. Extensive 
inhibition of this vital enzyme leads to accumulation of the neurotransmitter ACh 
and enhanced stimulation of postsynaptic cholinergic receptors and prevent the 
smooth transmission of nerve impulses across the synaptic gap at nerve junctions 
(Quinn, 1987, Pope et al., 2005). This causes loss of coordination, convulsion and, 
ultimately, death. Therefore, AChE is a key component of cholinergic brain synapses 
and neuromuscular junctions (Pope et al., 2005). Because of the essential role that 
AChE plays in the nervous system, this enzyme has long been an attractive target for 
the rational design of mechanism-based inhibitors (Giacobini, 2004). Cholinesterase 
inhibitors have been used in the treatment of human diseases such as Alzheimer's 
disease (AD), the control of insect pests such as by organophosphate insecticides 
(OP), and more notoriously as chemical warfare agents. Most uses of cholinesterase 
inhibitors are based on a common mechanism of action initiated by inhibition of 
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acetylcholinesterase (AChE) (Pope et al., 2005). The therapy that has been used as a 
potential strategy to improve AD pathology was mainly by inhibiting AChE (Ezoulin 
et al., 2005, Ferreira et al., 2006, Howes and Houghton, 2003). It has been suggested 
that the inhibition of AChE and BuChE enzymes should be one of the objectives in 
the treatment of cognitive dysfunctions associated with AD (Giacobini, 2004, Okello 
et al., 2004). A number of novel natural inhibitors of cholinesterases (AChE and 
BuChE) isolated from different medicinally-important plants has been previously 
reported. For instance, new natural AChE and BuChE inhibitors were isolated from 
Ajuga bracteosa, Withania somnifera and Sarcococca hookeriana by Choudhary 
(2005a, 2005c). Consequently, in the second experiment of this work, the plant 
species of Camellia sinensis; Myrtus communis; Alhagi maurorum; Urginea 
maritime; Olea europaea; Matricaria chamomilla; Hibiscus sabdariffa; Quercus 
robur; Syzygium aromaticum; and Zingiber officinale, which have various 
ethnobotanical uses, were examied for their anticholinesterase (AChE and BuChE) 
activities. 
Most the plant extracts analyzed exhibited various inhibitory activities toward 
both enzymes. According to their activities, plant extracts were divided into four 
categories (Table 3.3, Chapter 3). The first category includes the plants that did not 
show any inhibitory activities. The second category includes the plants that showed 
low activity (1- 25% inhibition); the third category contains the plants that exhibited 
moderate activity (25-50% inhibition) and the last category represented the plants 
which possess high activity (50-100% inhibition). 
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The results for hot extracts of green tea (Camellia sinensis) (Table 3.1) were 
0.068 ± 0.001mg/ml and 0.066 ± 0.004mg/ml (IC50 values). Similar inhibitory 
activities were obtained from the hot extract of S. aromaticum with IC50 of 0.075 ± 
0.003 mg/ml and 0.116 ± 0.007 mg/ml toward the AChE and BuChE enzymes 
respectively. Thus the extracts of these plants with single or dual anticholinesterase 
activity may be the most appropriate for clinical trials among the plant extracts 
investigated here. To the best knowledge of the auther, all the plant extracts screened 
and reported in this thesis showing high inhibitory activity (except green tea) are 
reported here for the first time as cholinesterase inhibitors. 
Focusing on the possible correlations between antioxidant and 
anticholinesterase activities, excluding the U. maritime extracts, all the plant extracts 
that have been identified in this study to possess a noticeable inhibitory activity 
against either AChE or BuChE or both were found to have a potent antioxidant 
activity and presented in group (a) (Table 2.4, Chapter 2 and Table 3.3, Chapter 3). 
These interesting observations are consistent with a recent study by Ferreira et al 
(2006) who reported that the extracts of Hypericum undulatum, Melissa officinalis, 
Laurus nobilis and Lavandula pedunculata which showed high antioxidant values 
also possess strong anticholinesterase activities. This may be explained by the 
presence of components with dual functions. Further studies are needed to fractionate 
the tested extracts and test each fraction for both activities (antioxidant and 
anticholinesterase) to confirm this correlation. In contrast, there appears to be no 
direct correlation between antioxidant and anticholinesterase activities in cacti. These 
results are consistent with that of Godkar et al. (2006), who reported that seed oil of 
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Celestrus panicultus exhibited a potent antioxidant capacity using the DPPH assay 
and showed no inhibitory activity against AChE at all. 
There was good agreement between the antioxidant activity (especially for 
the FRAP assay) and the extraction method used in folklore for most plant species. 
For instance, N. oleander, M. chamomilla, T. vulgaris, S. officinalis and 0. europaea 
were suggested to be used only as a hot infusion in the traditional uses. These results 
showed a higher antioxidant activity for those plants in hot extracts. Similarly, for 
those suggested to be used as cold infusions such as Q. robur and S. aromaticum, the 
highest activities have been found in the cold extracts (El Gadi, 1992). These results 
suggested that the efficiency of these plants could be explained, at least in part by 
their antioxidant activity. M. communis is reported by Romani et al., (2004) to have 
the same main polyphenols that exist in green tea, such as galloyl derivatives, and 
this can explain the high antioxidant capacity of M. communis. In addition, Abdel- 
Wahhab and Aly (2005) have demonstrated that the antioxidant capacity of S. 
aromaticum is due in part to the contribution of aromatic chemicals such as eugenol 
and eugenol acetate. 
The results obtained in this thesis indicate that there is a correlation between 
the medicinal uses and the antioxidant categories. For instance, most of the plants 
that grouped in category (a), such as green tea, S. officinale, Q. robur and M. 
communis were found to be used as astringents and as stimulants to the central 
nervous system (CNS). On the other hand, the plants that grouped in category (b) are 
more varied but in general most of them such as 0. europaea, P. tortousus and H. 
sabdariffa are used for the treatment of blood pressure and diabetes. The plants of 
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category (c) such as Z. officinale and U. martima were found to treat heart diseases 
or respiratory disorders (see Table 1.5, Chapter 1). There is potential opportunity, 
therefore, to target particular plant species to particular diseases. This is clearly an 
area where further study will be important. 
Digestion is an initial step involving changes in pH and activity of proteolytic 
enzymes (Serrano et al., 2007). Some of the antioxidant compounds can be 
inactivated and digested along the gastro-intestinal tract thus destroying the 
antioxidant pharmacological properties of these molecules. It is extremely important 
to evaluate possible changes in antioxidant properties and anticholinesterase activity 
of these plant extracts during digestion to test if the aqueous extracts will be able to 
survive in the gut and therefore still be of pharmacological use. According to their 
antioxidant activity, plants were divided into three categories: group (a), high 
antioxidant; group (b), moderate antioxidant and group (c), low antioxidant (see 
chapter 2). Four plant species from group (a), three from group (b) and three from 
group (c) as shown in Table 6.1 were selected for experiments on antioxidant 
property changes during in vitro digestion. Only those plant extracts that showed 
acceptable high anticholinesterase activities were chosen for in vitro 
anticholinesterase release experiments (see Chapter 3). 
The apparent antioxidant activity (assayed by the FRAP method) for green 
tea, M. communis, Q. robur, S. aromaticum, 0. europaea, M. chamomilla and U. 
niaritinia remained constant under acidic conditions and following partial protein 
hydrolysis then decreased under the alkaline conditions. This suggests that the 
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stability or antioxidant redox potential of some phenolic compounds is highly 
influenced by pH and the intestinal medium produces considerable changes. This 
suggests that most antioxidants would be most available in the first stage of the 
digestion process. The increased FRAP values at the end of the digestion step (after 
90 min) (figure 4.2, G and H) could be explained by the ability of plant phenols to 
complex with protein by hydrogen bonding and during protein hydrolysis release 
more antioxidant (Duodu et al., 2003, McDougall et al., 2005). In general, the initial 
release of antioxidant in water confirms the presence of water soluble compounds 
which are probably in a free form within these extracts. 
The results obtained by the TEAC assay (figure 4.3) and the DPPH assay 
(figure 4.4) showed significant release of antioxidant capacity at the final step of the 
in vitro digestion procedure (after 90min) in most extracts tested. Many flavonoids 
occur in plants in the glycosidic form and need to be heated with HCl to release the 
free flavonoids (Harborne, 1984). In addition, it was clearly demonstrated that some 
polyphenols are normally detected after acid or alkaline hydrolysis of plant tissue 
(Harborne, 1984). This could explain the high release of antioxidant capacity after 
addition of the HCl in all plant extracts with high antioxidant activity (group a) 
(figure 4.3, A, B, C and D and figure 4.4, A, B, C and D). The extracts which showed 
high TEAC values could contain substances that have a redox potential lower than 
that of the ABTS' radicals. Indeed, many phenolic compounds have low redox 
potentials and can thus react with the ABTS' radical (Frankel et al 2000; Prior et al 
2005). In general, it appears clearly that the variation in antioxidant activity detected 
by the three assays are due to the structure and chemistry of the individual 
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polyphenols, their ability to chelate metal and scavenge free radicals as well as the 
chemistry involved in the antioxidant analysis. Thus further structural analysis of 
these components in the extracts tested will be essential to further explore their 
potential for use in vivo. 
Almost all anticholinesterase activity was lost at the HC1 stage of the in vitro 
digestion procedure. These results indicate that these extracts are susceptible to 
digestive hydrolysis and they need to be commercially extracted and processed (for 
example protected by coverage with proteins or lipids) for their possible therapeutic 
usage as cholinesterase inhibitors. Further studies to fractionate the active extracts 
are now needed to identify active bio-ingredient and to establish the exact 
mechanism of action in order to explain their therapeutic efficacy. 
Testing in vitro bioavailability of plant extracts is a useful step in predicting 
in vivo bioavailability. Ingestion of plant extracts (as supplements after commercial 
procedures) may help to prevent in vivo oxidation damage which is associated with 
many diseases including cancer, diabetes and arteriosclerosis. The plants investigated 
in this study could provide protection against oxidative stress. However, it is not 
known which of the components of the aqueous extracts are responsible for this 
phenomenon. A bio-guided fractionation in order to elucidate the active principles 
should be involved in further investigations which may lead to extraction and 
production of active compounds in single or combined forms with useful application. 
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It should be emphasised that this study was focused on the possibility of 
using these extracts as natural sources for antioxidants and cholinesterase inhibitors 
which could possibly be used in future therapy. The results obtained here are 
promising and therefore further investigations should be targeted on such important 
issue as toxicology, stability processing as commercial products (highest possible 
activity and absence of smell). The experience with many other antioxidatively- 
active natural products such as Ginkgo and sage preparations shows that all the 
above-mentioned steps toward commercial products are time consuming and need 
detailed follow-up studies. These in vitro results provide some scientific validation 
for the widespread use of these plants in traditional medicine. However, these data 
represent a first crucial step that could be followed up with further in vivo studies. 
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